Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016724	p-hcyst	umol/l (umol/l)	2780	3833	0.03%
3016724	p-hcyst	— (—)	184	203	100.00%	Distribution not available
3016724	fp-hcyst	umol/l (umol/l)	101	105	0.00%
3016724	fp-hcyst	— (—)	18	18	100.00%	Distribution not available
3016724	homokysteiini	umol/l (umol/l)	11	14	0.00%	Distribution not available
3016724	s-hcyst	umol/l (umol/l)	9	11	0.00%	Distribution not available	Distribution not available
3016724	p-homokysteiini	umol/l (umol/l)	6	6	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

IBD (strict) with PSC

168

216.12

307.65

1.9

1.4

11.15

10.00

umol/l

0.51

168

Colitis, primary sclerosing, strict definition

161

166.09

307.65

1.9

1.3

11.16

10.69

umol/l

0.19

161

Cholangitis (primary sclerosing, PSC)

281

132

23.75

307.65

1.8

1.4

11.28

13.02

umol/l

1.80

281

125

Colitis, primary sclerosing

200

151.84

307.65

1.9

1.2

11.07

10.24

umol/l

0.44

200

Ulcerative colitis (strict) with PSC

136

189.51

276.24

1.9

1.4

11.28

10.23

umol/l

0.42

136

STROKE

584

922

4.37

199.26

1.2

1.4

12.15

11.47

umol/l

1.47

572

873

Cerebrovascular diseases (FINNGEN)

426

534

5.76

198.82

1.3

1.4

11.64

10.87

umol/l

1.47

417

508

Stroke, excluding SAH

507

1011

3.70

143.62

1.2

1.5

12.37

13.53

umol/l

3.02

489

943

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

807

2016

2.78

142.45

1.4

13.29

11.59

umol/l

7.39

776

1907

Ischaemic Stroke, excluding all haemorrhages

479

951

3.79

141.19

1.2

1.5

12.35

13.58

umol/l

3.14

464

887

Cerebrovascular diseases

610

1335

3.24

140.26

1.3

1.4

12.55

12.97

umol/l

0.71

588

1253

Hard cardiovascular diseases

695

1368

3.06

137.96

1.4

13.01

11.68

umol/l

4.86

671

1296

Stroke, including SAH

524

1096

3.51

137.02

1.2

1.5

12.37

13.46

umol/l

2.76

505

1025

Cardiovascular diseases (excluding rheumatic etc)

584

1082

3.13

119.20

1.4

11.61

10.07

umol/l

6.62

564

1018

Coagulation defects, purpura and other haemorrhagic conditions

244

497

5.02

112.29

1.4

1.5

12.26

12.46

umol/l

0.17

239

466

IBD patients in KELA-register

283

658

4.38

110.57

1.7

1.3

10.96

11.98

umol/l

2.39

278

620

Noninfective enteritis and colitis

436

1362

3.23

110.00

1.6

1.4

11.54

12.05

umol/l

0.94

428

1280

Mucosal proctocolitis

199

345

5.93

109.64

1.8

1.4

11.18

11.98

umol/l

1.06

199

321

Inflammatory bowel disease, strict (require KELA)

283

678

4.25

106.34

1.7

1.3

10.96

11.94

umol/l

2.25

278

641

Inflammatory bowel disease

336

915

3.73

105.46

1.7

1.3

11.27

12.16

umol/l

1.90

330

869

First line medication for Crohn's disease

813

1904

2.32

93.31

1.5

1.3

12.13

11.86

umol/l

0.48

784

1791

Cardiovascular diseases

507

945

2.91

89.70

1.4

11.40

10.02

umol/l

4.76

489

886

Any gastric operation

585

1092

2.70

89.11

1.5

1.2

11.92

11.09

umol/l

1.97

563

1025

GASTRO-related operations

585

1092

2.70

89.11

1.5

1.2

11.92

11.09

umol/l

1.97

563

1025

Sequelae of cerebrovascular disease

278

637

3.81

86.66

1.3

1.5

12.64

13.94

umol/l

1.98

267

593

Malaise and fatigue

394

1043

3.07

86.47

1.4

13.36

12.03

umol/l

2.42

367

989

Venous thromboembolism

409

1369

2.91

85.76

1.3

1.4

12.98

12.94

umol/l

0.04

387

1291

Inflammatory bowel disease treatment related agents

808

2085

2.18

81.09

1.5

1.3

12.30

11.86

umol/l

0.95

778

1963

DVT of lower extremities and pulmonary embolism

322

1017

3.19

79.48

1.4

13.23

13.15

umol/l

0.07

305

956

ILD medications: immunosuppressive drugs

495

1842

2.52

77.48

1.5

1.4

13.03

11.76

umol/l

3.65

482

1742

Adjustment and management of implanted device

168

343

4.98

77.12

1.5

15.78

13.60

umol/l

2.71

163

313

Autoimmune diseases related-to ILD

613

2307

2.29

76.47

1.5

1.3

11.83

12.15

umol/l

0.60

598

2172

Pulmonary heart disease, diseases of pulmonary circulation

261

751

3.52

75.47

1.4

13.73

13.40

umol/l

0.29

246

707

Pulmonary heart disease

245

684

3.63

74.20

1.4

13.41

13.34

umol/l

0.05

230

642

Pulmonary embolism

245

684

3.63

74.20

1.4

13.41

13.37

umol/l

0.03

230

642

Disorders of gallbladder, biliary tract and pancreas

679

1939

2.22

73.66

1.5

1.3

12.32

12.19

umol/l

0.16

652

1839

Reimbursement for rheumatic diseases

428

1666

2.58

71.64

1.6

1.4

11.83

12.22

umol/l

0.60

418

1575

Any reimbursement code in KELA

434

775

2.83

71.62

1.5

1.2

11.60

9.90

umol/l

6.15

409

748

Examination and observation for other reasons

448

979

2.67

69.83

1.5

1.3

12.45

11.93

umol/l

0.67

420

935

Persons encountering health services for specific procedures and health care

735

2112

2.10

68.46

1.4

13.26

11.47

umol/l

7.82

700

2006

General symptoms and signs

721

1688

2.15

68.08

1.4

12.35

11.56

umol/l

2.13

679

1600

Other heart diseases

369

849

2.86

67.83

1.5

1.4

13.22

10.42

umol/l

11.61

360

808

ILD medications

771

2037

2.06

66.98

1.4

1.3

12.47

11.76

umol/l

1.79

736

1924

Heart failure and coronary heart disease

292

653

3.20

66.28

1.5

1.4

17.16

13.68

umol/l

8.28

284

606

Autoimmune diseases excluding thyroid diseases

700

1818

2.11

64.76

1.5

1.3

12.23

umol/l

0.01

673

1712

ILD medications: prednisolone, methylprednisolone, prednisone

734

1999

2.06

64.48

1.4

12.47

11.81

umol/l

1.50

700

1889

Transient ischemic attack

332

953

2.84

64.08

1.3

1.5

12.72

13.47

umol/l

0.95

323

886

Heart failure, not strict

487

1395

2.39

63.51

1.5

1.4

16.36

11.76

umol/l

26.13

467

1320

Autoimmune diseases excluding thyroid diseases, strict definition

675

1751

2.12

63.29

1.5

1.3

12.22

12.21

umol/l

0.01

648

1647

Heart failure,strict

345

871

2.82

63.16

1.5

1.4

16.29

12.61

umol/l

13.21

334

817

Implicit Sepsis

548

1809

2.23

62.19

1.4

14.25

11.94

umol/l

8.55

523

1716

Fever of other and unknown origin

381

1333

2.56

61.60

1.4

13.12

11.74

umol/l

3.20

369

1264

Dental caries

239

712

3.27

61.01

1.4

14.24

11.73

umol/l

5.69

231

679

Implicit bacterial Sepsis

276

816

3.02

60.86

1.4

1.5

15.57

13.11

umol/l

4.66

265

763

Condition for Implicit Sepsis (Organ dysfunction codes)

567

1846

2.18

60.63

1.5

1.4

14.30

11.80

umol/l

10.07

540

1749

Condition for Implicit Sepsis (Organ dysfunction codes)

600

1948

2.13

60.59

1.4

14.01

11.55

umol/l

10.88

568

1856

Cardiac arrhythmias

418

1085

2.52

60.48

1.5

1.4

12.87

10.60

umol/l

9.89

404

1042

Other neurological diseases

466

1575

2.34

60.33

1.3

1.4

12.48

12.83

umol/l

0.46

448

1486

Used for control exclusion in common control thyroid runs

689

1681

2.08

60.16

1.6

1.3

11.95

12.24

umol/l

0.49

656

1584

Bacterial infection, other or unspecified

386

1302

2.52

59.86

1.4

13.65

12.46

umol/l

2.36

369

1228

Bacterial Sepsis

307

944

2.80

58.55

1.4

15.27

12.79

umol/l

5.30

292

888

Implicit Sepsis

492

1656

2.25

57.93

1.4

14.54

12.09

umol/l

8.54

468

1571

Implicit bacterial Sepsis

294

900

2.84

57.80

1.4

15.38

12.92

umol/l

5.13

282

845

Bacterial infection, other or unspecified

353

1194

2.58

57.79

1.4

13.84

12.55

umol/l

2.49

340

1120

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

332

759

2.78

57.64

1.3

1.4

11.66

10.42

umol/l

3.54

322

724

Heart failure, strict

357

966

2.63

57.34

1.5

1.4

16.37

13.23

umol/l

10.03

345

905

Autoimmune diseases

717

1826

2.01

57.04

1.5

1.3

11.71

12.22

umol/l

1.15

688

1720

Atrial fibrillation and flutter

245

488

3.29

56.56

1.5

1.4

14.55

11.22

umol/l

9.66

238

466

146

350

4.24

55.08

1.5

1.4

13.23

11.25

umol/l

2.76

140

338

Diseases of liver

264

947

2.82

52.68

1.6

1.4

12.92

12.64

umol/l

0.24

250

897

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

636

2098

1.98

52.25

1.5

1.3

13.75

11.53

umol/l

10.41

614

1990

Oral corticosteroids

662

2011

1.96

51.63

1.4

1.3

12.33

11.90

umol/l

0.85

635

1898

Ulcerative ileocolitis

108

7.33

51.11

1.9

1.5

10.55

11.59

umol/l

0.85

Caries of dentine

205

640

3.15

49.65

1.4

14.36

11.77

umol/l

5.22

198

613

Hypertensive diseases (excluding secondary)

353

824

2.50

49.03

1.4

13.20

10.34

umol/l

9.84

341

786

Other ulcerative colitis

152

5.97

48.93

1.8

1.5

11.22

11.70

umol/l

0.30

142

Presence of cardiac and vascular implants and grafts

281

778

2.70

48.57

1.6

1.4

15.79

13.80

umol/l

3.74

271

724

Pacemaker

207

650

3.08

48.15

1.6

1.4

14.99

14.42

umol/l

0.48

202

598

Nutritional anaemias

312

1247

2.43

45.98

1.5

1.4

14.01

12.45

umol/l

2.40

297

1175

Other heart diseases, wide

606

1927

1.93

45.65

1.5

1.4

13.03

11.17

umol/l

8.91

585

1826

Atrial fibrillation and flutter with reimbursement

189

360

3.37

45.20

1.6

1.4

15.59

11.66

umol/l

8.81

181

344

Anxiety disorders, excluding more controls

527

1737

1.98

43.45

1.4

11.26

11.96

umol/l

1.58

490

1680

Renal failure

273

962

2.53

43.06

1.4

18.18

13.29

umol/l

12.72

268

895

Percutaneous Coronary Intervention

477

1439

2.04

42.01

1.5

1.4

14.70

11.96

umol/l

11.20

457

1367

Symptoms and signs involving cognition, perception, emotional state and behaviour

589

2150

1.88

41.71

1.3

1.4

12.90

11.97

umol/l

2.02

557

2046

Other bacterial diseases

573

2043

1.89

41.65

1.4

14.06

11.79

umol/l

9.39

553

1927

Persons encountering health services for other counselling and medical advice, not elsewhere classified

679

2035

1.82

41.60

1.5

1.4

12.36

11.99

umol/l

0.67

632

1936

Care involving use of rehabilitation procedures

391

1703

2.12

41.60

1.3

1.4

12.72

11.76

umol/l

1.86

374

1616

Gastrointestinal diseases

385

855

2.27

41.50

1.5

1.3

11.84

10.89

umol/l

1.84

368

812

Nonischemic cardiomyopathy

204

4.74

41.25

1.6

1.5

14.87

13.24

umol/l

1.42

188

All-cause Heart Failure

317

952

2.36

41.24

1.5

1.4

16.23

13.24

umol/l

8.15

305

892

Emergency coronary revascularization (for ACS)

500

1533

1.99

41.12

1.5

1.4

14.69

12.16

umol/l

9.94

479

1457

Coronary revascularization (ANGIO or CABG)

475

1441

2.03

41.09

1.5

1.4

14.69

11.96

umol/l

11.12

455

1369

Phlebitis and thrombophlebitis (not including DVT)

170

561

3.06

39.63

1.3

1.5

12.38

12.44

umol/l

0.04

164

524

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

243

440

2.79

39.52

1.5

1.3

11.77

10.96

umol/l

0.99

229

409

Persons encountering health services in other circumstances, wide

700

2040

1.77

38.90

1.4

12.58

11.99

umol/l

1.27

657

1941

Other pulmonary heart/vessel disease

7.19

38.69

1.6

1.5

15.11

15.76

umol/l

0.20

Neurotic, stress-related and somatoform disorders

566

2156

1.84

38.34

1.4

11.11

11.96

umol/l

2.42

527

2064

Anxiety disorders

569

2169

1.84

37.94

1.4

11.09

11.98

umol/l

2.61

530

2077

Other bacterial diseases

609

2147

1.81

37.84

1.4

13.69

11.61

umol/l

9.15

587

2026

Endocrine, nutritional and metabolic diseases

509

1335

1.94

37.11

1.4

12.06

11.14

umol/l

2.09

476

1285

Major coronary heart disease event

487

1527

1.93

36.83

1.5

1.4

14.68

11.99

umol/l

11.11

466

1449

Metabolic disorders

561

1866

1.84

36.76

1.4

12.94

11.85

umol/l

2.80

531

1773

Cardiodefibrillation

209

803

2.62

36.45

1.4

14.74

13.97

umol/l

0.82

198

753

Medical observation and evaluation for suspected diseases and conditions

400

988

2.08

35.37

1.4

1.3

12.49

11.99

umol/l

0.66

374

944

Other anaemias

244

970

2.41

35.36

1.6

1.4

15.72

13.25

umol/l

4.06

232

904

Abnormalities of breathing

540

1706

1.85

35.28

1.4

1.3

13.00

11.59

umol/l

4.39

514

1615

Statin medication

448

1284

1.97

35.20

1.4

12.11

10.98

umol/l

2.88

432

1222

Iron deficiency anaemia

254

1073

2.35

35.05

1.4

13.73

12.18

umol/l

2.04

241

1016

Ischemic heart diseases

482

1525

1.91

34.99

1.5

1.4

14.29

11.86

umol/l

9.74

464

1445

Aplastic and other anaemias

257

1031

2.34

34.77

1.6

1.4

15.71

13.19

umol/l

4.50

245

965

Other and unspecified anaemias

241

963

2.40

34.75

1.6

1.4

15.81

13.26

umol/l

4.21

229

897

Certain infectious and parasitic diseases

578

1598

1.82

34.70

1.4

1.3

12.49

11.45

umol/l

2.91

544

1513

Implicit viral Sepsis

145

473

3.10

34.55

1.3

1.4

14.67

12.50

umol/l

2.58

138

444

Mood disorders, excluding more controls

549

1808

1.82

34.50

1.3

1.4

11.91

12.07

umol/l

0.21

504

1746

Anxiety (asthma-related co-morbidities)

401

1572

1.98

34.48

1.4

10.90

11.45

umol/l

1.00

369

1525

Viral Sepsis

145

474

3.09

34.43

1.3

1.4

14.67

12.49

umol/l

2.61

138

445

Implicit viral Sepsis

187

703

2.68

34.26

1.4

14.19

12.34

umol/l

2.62

179

661

Tramadol

475

1545

1.90

34.18

1.4

12.98

11.72

umol/l

3.46

455

1464

Complications of surgical and medical care, not elsewhere classified

574

2228

1.77

34.00

1.4

12.53

12.06

umol/l

0.86

548

2113

Extrapyramidal and movement disorders

226

936

2.43

33.86

1.7

1.4

14.48

12.74

umol/l

2.76

219

874

Neurological diseases

519

1403

1.87

33.81

1.4

11.89

11.53

umol/l

0.54

492

1338

Heart failure and bmi 25plus

194

481

2.74

33.78

1.4

16.95

13.52

umol/l

6.59

185

449

Other diseases of intestines

635

2094

1.73

33.41

1.4

12.12

11.79

umol/l

0.55

602

1989

Other and unspecified iron deficiency

206

829

2.50

32.81

1.3

1.4

13.63

12.28

umol/l

1.34

194

783

Use of pramipexole

149

514

2.93

32.22

1.8

1.4

14.04

12.53

umol/l

1.53

143

482

All anxiety disorders

406

1676

1.92

32.15

1.4

10.89

11.49

umol/l

1.18

373

1607

Intestinal infectious diseases

557

2434

1.74

31.90

1.4

12.60

11.96

umol/l

1.15

528

2307

Headache

379

1551

1.96

31.81

1.4

11.34

11.41

umol/l

0.07

357

1472

Symptoms and signs involving the circulatory and respiratory systems

597

1714

1.75

31.76

1.4

1.3

11.90

11.58

umol/l

0.50

570

1622

Continuous positive airway pressure

121

306

3.36

31.60

1.4

1.5

13.80

11.52

umol/l

2.77

116

301

Complications of procedures, not elsewhere classified

467

2133

1.82

31.41

1.4

12.23

12.04

umol/l

0.26

445

2022

Arterial embolism and thrombosis

5.94

31.34

1.4

1.6

13.81

13.89

umol/l

0.02

Dyspnoea

512

2140

1.77

31.07

1.5

1.4

13.95

11.86

umol/l

7.07

491

2029

Pain in throat and chest

496

1648

1.81

31.01

1.4

1.3

11.94

11.66

umol/l

0.38

471

1559

Intestinal infectious diseases

658

2263

1.67

30.28

1.4

12.53

12.00

umol/l

0.97

626

2146

Dizziness and giddiness

418

1784

1.86

30.22

1.4

13.04

12.17

umol/l

1.37

397

1691

Second line medication for Crohn's disease

358

1859

1.94

30.13

1.4

12.62

11.89

umol/l

1.30

350

1763

Opioids

576

1733

1.73

29.85

1.4

12.19

11.54

umol/l

1.42

554

1633

Neurological diseases, wide definition

217

432

2.54

29.84

1.4

11.29

10.79

umol/l

0.51

206

406

Mood disorders

597

2294

1.69

29.72

1.3

1.4

11.72

12.04

umol/l

0.57

549

2196

Mood [affective] disorders

596

2294

1.69

29.68

1.3

1.4

11.71

12.04

umol/l

0.58

548

2196

All chronic kidney diseases

299

1185

2.07

29.48

1.4

17.32

12.03

umol/l

15.75

286

1117

Depression

561

2247

1.70

28.72

1.3

1.4

11.57

11.99

umol/l

0.79

517

2152

Other anxiety disorders

307

1323

2.02

28.60

1.4

10.92

11.41

umol/l

0.70

284

1271

Diarrhoea and gastroenteritis of presumed infectious origin

581

2286

1.68

28.52

1.4

12.22

11.97

umol/l

0.35

551

2168

Other soft tissue disorders, not elsewhere classified

555

1909

1.71

28.30

1.4

12.06

12.02

umol/l

0.05

531

1806

Infections, IBD-co-morbidities

107

222

3.47

28.02

1.5

1.4

14.78

11.49

umol/l

3.22

102

209

Diarrhoea and gastroenteritis of presumed infectious origin

418

2094

1.81

27.90

1.4

12.60

11.84

umol/l

1.20

394

1993

Codes for special purposes

315

1608

1.97

27.82

1.4

13.16

11.87

umol/l

2.47

302

1523

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

534

2006

1.71

27.80

1.4

12.51

12.26

umol/l

0.38

512

1902

Other diseases of liver

133

473

2.84

27.30

1.6

1.4

12.42

12.49

umol/l

0.04

126

448

Renal tubulo-interstitial diseases

477

2047

1.74

27.28

1.4

15.62

11.49

umol/l

20.30

462

1936

Episodal and paroxysmal disorders

617

1901

1.66

27.14

1.4

11.64

12.01

umol/l

0.65

583

1809

Provisional assignment of new diseases of uncertain etiology

313

1609

1.95

27.10

1.4

13.20

11.87

umol/l

2.60

300

1524

Antihypertensive medication - note that there are other indications

396

1123

1.88

26.80

1.4

11.78

10.05

umol/l

5.70

372

1079

Complications of medical and surgical care

408

2100

1.79

26.77

1.4

12.31

12.23

umol/l

0.08

389

1990

L04AX Other immunosuppressants

336

1783

1.89

26.57

1.4

12.74

11.85

umol/l

1.67

328

1692

All kidney diseases

550

2268

1.66

26.17

1.4

15.05

11.24

umol/l

20.99

532

2151

Bleeding

439

1778

1.76

25.98

1.4

13.57

12.48

umol/l

2.27

420

1685

Pain in limb

473

1835

1.73

25.96

1.4

12.73

12.00

umol/l

1.31

451

1743

Non-ischemic cardiomyopathy

168

544

2.50

25.72

1.5

1.4

14.90

13.33

umol/l

2.00

161

510

Other antidepressants

575

1778

1.66

25.67

1.4

11.95

12.41

umol/l

0.78

536

1701

Exposure to unspecified factor

562

2478

1.64

25.45

1.4

12.06

12.03

umol/l

0.04

529

2354

Total colectomy operation

113

5.00

25.42

1.6

1.5

11.90

12.20

umol/l

0.13

106

Total colectomy

113

5.00

25.42

1.6

1.5

11.90

12.20

umol/l

0.13

106

Other medical care

236

1004

2.12

25.36

1.3

1.4

13.63

12.38

umol/l

1.60

222

943

Syncope and collapse

236

954

2.13

25.25

1.3

1.4

13.97

12.30

umol/l

2.55

221

902

Influenza and pneumonia

594

2338

1.62

25.21

1.4

13.38

11.52

umol/l

7.46

558

2223

Migraine

304

1273

1.95

25.19

1.3

1.4

10.46

11.15

umol/l

1.07

287

1218

Congenital malformations, deformations and chromosomal abnormalities

365

1924

1.81

25.07

1.3

1.4

10.70

11.55

umol/l

2.16

350

1825

504

1810

1.69

24.98

1.4

13.32

11.56

umol/l

5.74

471

1716

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

504

1810

1.69

24.98

1.4

13.32

11.56

umol/l

5.74

471

1716

Pain (limb, back, neck, head abdominally)

417

1162

1.80

24.67

1.5

1.3

12.80

12.04

umol/l

1.23

400

1087

Any death

322

1215

1.91

24.54

1.4

14.87

13.01

umol/l

3.53

299

1152

Pain, not elsewhere classified

170

721

2.37

24.33

1.4

12.33

11.47

umol/l

0.84

159

686

Other arrhythmias

357

1477

1.83

24.28

1.4

12.91

11.42

umol/l

3.78

345

1397

Haemolytic anaemias

6.28

24.18

2.2

1.6

14.32

13.22

umol/l

0.26

Oedema, not elsewhere classified

171

723

2.35

23.83

1.4

13.34

12.25

umol/l

0.98

161

684

Congenital malformations, deformations and chromosomal abnormalities

388

2043

1.76

23.83

1.3

1.4

10.78

11.60

umol/l

2.02

370

1942

Symptoms and signs involving the digestive system and abdomen

550

1676

1.65

23.79

1.5

1.3

12.23

12.14

umol/l

0.11

523

1584

Pneumonia, organism unspecified

503

2139

1.65

23.63

1.4

13.72

11.66

umol/l

6.98

469

2039

Any mental disorder

591

1840

1.61

23.44

1.4

11.98

12.12

umol/l

0.19

551

1775

Diseases of oesophagus, stomach and duodenum

578

2159

1.61

23.42

1.4

12.51

11.89

umol/l

1.30

541

2059

Hypertensive diseases

454

1499

1.72

23.37

1.4

13.52

11.17

umol/l

8.92

435

1431

Other disorders of fluid, electrolyte and acid-base balance

162

654

2.37

23.01

1.3

1.4

15.35

13.13

umol/l

1.97

151

615

Disorders of the thyroid gland

505

2006

1.64

22.91

1.4

1.3

11.33

12.40

umol/l

2.91

484

1904

Hypothyroidism, strict autoimmune

369

1360

1.79

22.77

1.5

1.3

10.86

12.27

umol/l

3.48

352

1279

Oxycodone

201

844

2.17

22.77

1.3

1.4

13.04

12.84

umol/l

0.16

191

795

Hypertension

451

1498

1.71

22.73

1.4

13.52

11.17

umol/l

8.89

432

1430

Abnormalities of heart beat

202

933

2.13

22.39

1.4

11.67

12.04

umol/l

0.38

197

879

Polyneuropathies and other disorders of the peripheral nervous system

135

537

2.54

22.30

1.2

1.4

14.11

13.30

umol/l

0.47

124

507

Symptoms and signs involving the skin and subcutaneous tissue

383

2181

1.72

22.30

1.4

11.50

12.19

umol/l

1.30

372

2062

Covid-19 confirmed case

206

981

2.11

22.29

1.5

1.4

13.72

12.47

umol/l

1.73

195

929

Visual disturbances and blindness

287

1535

1.88

22.25

1.3

1.4

11.71

12.38

umol/l

0.90

277

1448

Persons encountering health services for specific procedures, not carried out

220

3.50

22.20

1.1

1.5

13.68

11.22

umol/l

1.47

205

Abnormal findings on examination of blood, without diagnosis

249

1162

1.98

22.19

1.5

1.4

12.95

13.28

umol/l

0.29

239

1093

All pneumoniae

556

2350

1.59

21.92

1.4

13.53

11.57

umol/l

7.50

522

2237

Other functional intestinal disorders

242

1138

1.98

21.79

1.5

1.4

12.34

12.41

umol/l

0.04

232

1085

Diseases of arteries, arterioles and capillaries

325

1322

1.82

21.78

1.4

13.88

13.11

umol/l

0.97

305

1250

Disturbances of skin sensation

183

841

2.19

21.74

1.3

1.4

10.97

11.67

umol/l

0.82

176

802

Recurrent or chronic depression

252

895

1.99

21.71

1.3

1.4

11.67

11.86

umol/l

0.18

238

873

Septicaemia

211

954

2.08

21.68

1.4

14.31

12.76

umol/l

2.22

202

890

Other symptoms and signs involving cognitive functions and awareness

229

1037

2.02

21.67

1.3

1.4

13.20

13.01

umol/l

0.14

213

975

Pneumonias (Asthma/COPD co-morbidities)

552

2348

1.58

21.62

1.4

13.56

11.59

umol/l

7.49

517

2235

Certain infectious and parasitic diseases

406

1170

1.74

21.55

1.5

1.4

12.60

11.72

umol/l

1.65

383

1104

Explicit Sepsis

222

1028

2.03

21.28

1.4

14.05

12.45

umol/l

2.45

212

970

Abdominal and pelvic pain

536

1676

1.61

21.25

1.5

1.3

12.07

12.14

umol/l

0.09

512

1584

Benign neoplasm: Colon

263

1325

1.90

21.15

1.4

13.58

13.32

umol/l

0.21

247

1252

Visual disturbances

271

1458

1.87

20.72

1.3

1.4

11.62

12.32

umol/l

0.91

262

1374

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

536

2328

1.57

20.63

1.4

13.56

11.63

umol/l

6.87

504

2213

Persons encountering health services for examination and investigation

352

988

1.79

20.53

1.5

1.3

12.83

11.99

umol/l

1.29

328

944

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

318

1777

1.77

20.49

1.4

12.29

12.35

umol/l

0.05

305

1684

Other reaction to severe stress, and adjustment disorders

226

1150

1.98

20.45

1.4

11.36

11.38

umol/l

0.02

211

1103

Haemorrhage from respiratory passages

176

732

2.18

20.31

1.5

1.4

13.86

12.93

umol/l

0.86

167

689

Disorders of lipoprotein metabolism and other lipidaemias

414

1530

1.68

20.30

1.3

1.4

13.10

12.30

umol/l

1.31

390

1450

General examination and investigation of persons without complaint and reported diagnosis

338

985

1.80

20.08

1.4

1.3

12.26

11.94

umol/l

0.39

323

941

Hypothyroidism, other/unspecified

460

1871

1.62

19.90

1.5

1.3

10.97

12.31

umol/l

4.08

441

1773

Diseases of the eye and adnexa

476

1466

1.63

19.87

1.3

1.4

11.78

umol/l

0.01

450

1400

Cholelithiasis, broad definition with cholecystitis

430

1768

1.64

19.63

1.4

12.88

12.18

umol/l

1.05

410

1675

Nausea and vomiting

150

651

2.27

19.45

1.4

1.3

13.33

12.21

umol/l

0.83

144

611

Benign neoplasm of colon, rectum, anus and anal canal

303

1497

1.76

18.85

1.4

13.49

13.19

umol/l

0.27

284

1419

Ulcer of lower limb, not elsewhere classified

320

2.84

18.64

1.4

1.5

16.59

13.50

umol/l

2.77

299

Other and unspecified polyneuropathies, also in other diseases

116

470

2.49

18.53

1.3

1.5

14.26

13.31

umol/l

0.55

106

443

Hypothyreosis and Thyroxine purchase for inclusion criteria

472

1963

1.58

18.47

1.5

1.3

10.94

12.34

umol/l

4.47

453

1859

Subjective visual disturbances

151

688

2.21

18.42

1.4

1.5

11.66

12.25

umol/l

0.40

146

650

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

294

1681

1.75

18.34

1.4

12.21

12.36

umol/l

0.15

281

1591

Other disorders of skin and subcutaneous tissue

347

1838

1.68

18.33

1.4

13.12

12.36

umol/l

1.19

330

1742

Special screening examination for infectious and parasitic diseases

166

566

2.17

18.29

1.3

10.63

10.90

umol/l

0.22

151

546

Pain in joint

310

1130

1.76

17.93

1.4

1.3

12.06

11.97

umol/l

0.08

292

1060

Codeine

486

1696

1.56

17.35

1.3

1.4

12.51

11.56

umol/l

1.92

463

1599

Pure hypercholesterolaemia

354

1387

1.67

17.27

1.3

1.4

13.91

12.49

umol/l

2.32

331

1314

Symptoms and signs involving the nervous and musculoskeletal systems

298

1748

1.71

17.06

1.3

1.4

13.25

12.15

umol/l

1.65

280

1659

Depression or dysthymia

350

1151

1.68

16.95

1.3

1.4

12.29

12.41

umol/l

0.10

332

1114

Chronic Coagulation defects

5.48

16.93

1.3

1.5

12.94

10.73

umol/l

1.01

Cholelithiasis

403

1737

1.60

16.93

1.4

12.84

12.18

umol/l

0.91

383

1644

Asthma, excluding more controls

402

1292

1.63

16.89

1.3

12.16

11.05

umol/l

2.31

384

1229

Hyperlipidaemia, other/unspecified

178

820

2.01

16.74

1.3

1.4

13.74

13.31

umol/l

0.32

172

767

Psychiatric diseases

510

1667

1.54

16.67

1.4

12.23

12.11

umol/l

0.15

474

1616

Symptoms and signs involving speech and voice

177

893

1.99

16.54

1.4

12.07

12.39

umol/l

0.27

169

844

Osteopathies and chondropathies

282

1533

1.72

16.32

1.5

1.4

13.48

12.26

umol/l

1.84

268

1456

Other diseases of blood and blood-forming organs, wide

127

572

2.24

16.01

1.4

12.83

umol/l

0.00

122

539

Constipation

439

1967

1.55

15.94

1.4

12.48

12.33

umol/l

0.16

415

1869

COPD/asthma/ILD related infections

541

1811

1.50

15.86

1.4

12.49

11.56

umol/l

2.22

504

1717

COPD/asthma related infections

541

1811

1.50

15.86

1.4

12.49

11.56

umol/l

2.22

504

1717

Chronic gastritis

137

639

2.16

15.82

1.4

14.02

13.32

umol/l

0.37

126

599

Diseases of the digestive system

224

1233

1.81

15.79

1.4

13.61

12.94

umol/l

0.67

218

1161

Migraine with aura

147

706

2.09

15.75

1.3

1.4

11.01

10.86

umol/l

0.11

140

677

Unspecified jaundice

4.23

15.32

1.7

1.4

11.72

14.26

umol/l

1.69

Other disorders of urethra and urinary system

345

1542

1.62

15.28

1.4

1.3

12.70

11.89

umol/l

1.17

324

1466

Gout, idiopatic and unspecified

123

558

2.22

15.26

1.3

1.4

17.45

14.16

umol/l

3.82

111

519

Hypertension, essential

401

1450

1.57

14.89

1.3

1.4

13.06

11.27

umol/l

5.68

383

1383

Gout, unspecified

107

464

2.32

14.80

1.3

1.4

17.83

14.19

umol/l

3.83

430

Fall on same level

601

2281

1.44

14.78

1.4

13.04

11.53

umol/l

5.23

562

2174

Gout

139

585

2.10

14.74

1.3

1.5

17.10

14.22

umol/l

3.53

126

554

Benzodiazepine use

513

2404

1.47

14.71

1.4

12.19

12.08

umol/l

0.12

475

2291

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

183

975

1.89

14.62

1.4

11.90

11.72

umol/l

0.13

178

927

Neoplasms

434

1500

1.54

14.51

1.4

11.40

11.67

umol/l

0.38

413

1424

Factors influencing health status and contact with health services

159

387

2.07

14.24

1.6

1.3

12.98

11.43

umol/l

1.98

150

369

Gout, FINNGEN

139

681

2.05

14.06

1.3

1.4

17.10

14.31

umol/l

3.39

126

640

Irritable bowel syndrome

149

753

1.99

13.95

1.3

1.4

10.78

11.62

umol/l

0.89

136

716

Peripheral artery disease

185

799

1.85

13.45

1.4

15.32

13.97

umol/l

1.32

175

752

Organic, including symptomatic, mental disorders

210

839

1.79

13.38

1.7

1.4

14.23

13.88

umol/l

0.26

193

782

Major coronary heart disease event excluding revascularizations

260

1036

1.68

13.09

1.5

1.4

15.43

12.89

umol/l

4.93

237

976

Procreative management

200

938

1.79

13.08

1.7

1.4

10.23

11.49

umol/l

2.99

193

890

Malignant neoplasm, wide definition for exclusion

449

1780

1.48

13.02

1.3

1.4

11.60

12.08

umol/l

0.81

437

1692

Excluding asthma or asthma-COPD overlap

423

1406

1.51

12.98

1.4

12.85

11.46

umol/l

3.36

399

1336

Abnormal serum enzyme levels

146

732

1.95

12.96

1.5

1.4

13.01

14.00

umol/l

0.93

138

682

Asthma

404

1396

1.52

12.92

1.3

1.4

12.18

11.46

umol/l

1.16

386

1327

Asthma (only as main-diagnosis), excluding more controls

352

1292

1.56

12.91

1.4

1.3

12.01

11.05

umol/l

1.87

339

1229

Asthma (mode)

398

1402

1.52

12.90

1.3

1.4

12.06

11.47

umol/l

0.89

381

1333

ILD differential diagnosis

421

1402

1.51

12.81

1.4

12.78

11.47

umol/l

3.10

397

1333

Codeine or tramadol medication

571

2214

1.41

12.74

1.3

1.4

12.51

11.85

umol/l

1.32

542

2097

Other headache syndromes

209

1211

1.73

12.66

1.3

1.4

10.67

11.77

umol/l

2.15

196

1154

Other special examinations and investigations of persons without complaint or reported diagnosis

313

988

1.61

12.64

1.4

1.3

12.42

11.99

umol/l

0.49

294

944

Gout, strict definition

389

2.33

12.62

1.3

1.4

16.82

14.52

umol/l

1.90

359

COPD differential diagnosis

420

1403

1.50

12.61

1.4

12.79

11.47

umol/l

3.16

396

1334

Coronary atherosclerosis

282

1098

1.63

12.60

1.6

1.4

14.82

12.61

umol/l

4.60

263

1037

Erysipelas

250

1343

1.65

12.51

1.4

15.02

12.56

umol/l

4.79

240

1261

Other pulmonary diagnosis

420

1406

1.50

12.49

1.4

12.78

11.46

umol/l

3.07

396

1336

Follow-up examination after treatment for conditions other than malignant neoplasms

212

804

1.75

12.46

1.4

1.3

11.95

12.03

umol/l

0.06

201

771

Asthma, unspecified (mode), excluding more controls

255

1159

1.65

12.39

1.3

1.4

12.68

11.09

umol/l

2.92

244

1110

Liquid cancers, helper endpoint

172

828

1.82

12.10

1.4

1.5

13.76

13.32

umol/l

0.31

166

777

Other external causes of accidental injury

424

1432

1.49

12.09

1.4

12.38

11.55

umol/l

1.54

399

1369

Intestinal stricture

144

757

1.91

12.08

1.4

14.06

13.12

umol/l

0.71

139

711

Selective serotonin reuptake inhibitors

492

1787

1.44

12.07

1.3

1.4

11.66

12.39

umol/l

1.61

460

1710

Parasetamol

407

1382

1.50

12.00

1.4

12.81

11.31

umol/l

3.66

382

1309

Myocardial infarction

207

845

1.73

11.81

1.5

1.4

16.06

13.08

umol/l

4.52

189

793

Use of rivastigmine

243

2.64

11.77

2.0

1.4

15.45

14.85

umol/l

0.22

225

562

2087

1.39

11.49

1.4

12.58

11.92

umol/l

1.35

536

1967

Other diseases of anus and rectum

138

727

1.90

11.45

1.3

1.4

13.21

12.74

umol/l

0.31

130

684

Other disorders of veins

188

1084

1.73

11.44

1.4

12.53

11.89

umol/l

0.64

182

1021

Intracranial trauma

259

1137

1.61

11.21

1.4

11.62

11.60

umol/l

0.02

248

1082

Dysphagia

115

578

2.00

11.05

1.4

1.3

12.02

12.93

umol/l

0.73

103

545

Diseases of the skin and subcutaneous tissue

502

1790

1.41

10.91

1.4

12.46

11.92

umol/l

0.91

471

1705

Cystitis

402

1642

1.46

10.88

1.4

1.3

11.76

11.85

umol/l

0.08

375

1562

Atherosclerosis, excluding cerebral and coronary sclerosis

164

727

1.79

10.87

1.3

1.4

15.44

14.17

umol/l

1.01

157

682

Disorders of other endocrine glands

213

1276

1.65

10.80

1.5

1.4

11.76

11.86

umol/l

0.07

207

1215

Accidents

415

1432

1.45

10.70

1.4

12.34

11.55

umol/l

1.40

391

1369

Other general symptoms and signs

108

3.43

10.67

1.4

1.6

9.92

11.02

umol/l

0.59

103

Erysipelas

321

1633

1.50

10.59

1.4

14.39

12.23

umol/l

5.31

307

1541

Cardiac arrest

3.52

10.43

1.8

1.5

14.24

13.20

umol/l

0.39

Diaphragmatic hernia

161

920

1.76

10.39

1.5

1.4

13.51

12.87

umol/l

0.53

150

875

Asthma (only as main-diagnosis)

356

1396

1.48

10.33

1.4

12.03

11.46

umol/l

0.85

343

1327

Injuries to the head

547

2468

1.36

10.26

1.4

13.04

11.82

umol/l

3.29

515

2346

Hypothyroidism, strict autoimmune, 3 medication purchases required

390

1831

1.44

10.20

1.5

1.3

10.75

12.27

umol/l

4.57

374

1735

Obsessive-compulsive disorder

187

2.76

10.18

1.2

1.5

10.12

11.00

umol/l

0.62

181

Nonpyogenic thrombosis of intracranial venous system

11.79

10.17

2.4

2.2

11.77

12.41

umol/l

0.09

Other diseases of urinary system

476

1917

1.40

10.16

1.4

12.35

11.99

umol/l

0.51

447

1827

Falls/tendency to fall

549

2010

1.37

10.15

1.4

12.75

11.49

umol/l

3.88

520

1917

Obesity related asthma

171

1002

1.71

10.11

1.3

1.4

13.51

12.15

umol/l

1.42

160

951

Myocardial infarction, strict

187

787

1.70

10.10

1.4

16.16

13.18

umol/l

4.18

169

738

Dementia, including avohilmo

166

651

1.76

10.10

1.7

1.4

15.16

14.38

umol/l

0.52

155

604

Congenital varicose veins

18.10

10.07

1.1

1.3

8.75

9.44

umol/l

—

Asthma, unspecified (mode)

258

1250

1.56

10.03

1.3

1.4

12.81

11.56

umol/l

1.95

247

1195

Migraine without aura

116

606

1.92

10.02

1.3

1.4

9.97

10.44

umol/l

0.28

109

585

Functional dyspepsia

132

719

1.84

10.02

1.5

1.4

12.17

12.14

umol/l

0.01

126

683

External causes of morbidity and mortality

340

1144

1.49

10.01

1.4

12.01

11.43

umol/l

0.80

321

1091

Dementia

156

603

1.79

10.00

1.7

1.4

14.58

14.62

umol/l

0.02

145

558

Valvular heart disease excluding rheumatic fever

201

878

1.66

9.98

1.4

14.55

12.23

umol/l

4.04

196

829

Generalized anxiety disorder

465

2.06

9.89

1.5

9.72

11.04

umol/l

1.87

448

Bronchitis

518

2393

1.37

9.82

1.3

1.4

12.75

11.90

umol/l

2.11

498

2258

Malignant neoplasm

413

1722

1.42

9.81

1.3

1.4

11.59

12.16

umol/l

0.98

401

1635

Immunodeficiencies

121

3.18

9.76

1.3

1.5

11.16

11.25

umol/l

0.03

112

Nonorganic sleeping disorders, excluding more controls

103

523

1.98

9.68

1.4

10.78

11.73

umol/l

0.57

507

Ischaemic heart disease, wide definition

338

1428

1.47

9.65

1.6

1.4

14.96

12.58

umol/l

6.00

314

1360

6-mercaptopurine

3.77

9.62

1.6

10.60

10.47

umol/l

0.05

Non-rheumatic valve diseases

197

865

1.65

9.59

1.4

14.64

12.26

umol/l

4.09

192

816

Personality disorders, excluding more controls

135

751

1.80

9.58

1.3

1.4

11.92

11.53

umol/l

0.23

118

732

Somatoform disorder

451

2.05

9.55

1.3

1.4

9.79

12.00

umol/l

4.40

435

Soft tissue disorders

516

1945

1.37

9.55

1.4

11.66

12.01

umol/l

0.56

500

1838

Speech therapy

125

682

1.84

9.47

1.3

1.4

12.51

12.60

umol/l

0.06

116

644

Other gastritis (incl. Duodenitis)

108

562

1.93

9.47

1.5

1.4

13.93

13.08

umol/l

0.57

101

529

Bacterial pneumonia, not elsewhere classified

167

868

1.70

9.45

1.3

1.4

14.59

12.73

umol/l

2.22

159

825

Explicit bacterial Sepsis

224

2.52

9.42

1.4

1.5

13.35

13.22

umol/l

0.04

208

Benign neoplasms

493

1985

1.37

9.39

1.4

12.11

11.99

umol/l

0.15

472

1885

Chronic pancreatitis

286

2.32

9.33

1.3

1.4

13.16

13.37

umol/l

0.08

268

Sleep disorders (combined)

547

2133

1.35

9.27

1.4

12.17

12.07

umol/l

0.11

516

2023

Any event in cancer register

448

1907

1.39

9.22

1.3

1.4

11.48

11.98

umol/l

0.83

435

1809

Diverticular disease of intestine

305

1317

1.48

9.16

1.4

13.75

12.74

umol/l

1.48

291

1248

Thrombotic microangiopathy

16.48

9.16

1.6

1.3

15.07

9.89

umol/l

—

Bacterial pneumoniae

174

924

1.66

9.14

1.3

1.5

14.46

12.68

umol/l

2.18

165

879

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

283

1707

1.49

9.14

1.4

13.86

12.78

umol/l

1.35

266

1616

Disorders of conjunctiva

406

2343

1.39

9.11

1.4

10.92

11.93

umol/l

2.47

385

2223

Benign neoplasm of other and ill-defined parts of digestive system

426

2.05

9.09

1.4

12.48

12.97

umol/l

0.26

402

Other viral diseases, not elsewhere classified

148

855

1.73

9.08

1.3

1.4

11.95

11.33

umol/l

0.51

141

818

Viral infections characterized by skin and mucous membrane lesions

205

1296

1.59

9.02

1.3

1.4

13.07

12.01

umol/l

1.34

191

1233

Autoimmune hepatitis

13.04

8.95

1.8

1.9

10.13

10.77

umol/l

0.20

Myalgia

121

668

1.82

8.86

1.4

10.86

11.63

umol/l

0.81

116

633

Cough

182

1063

1.62

8.80

1.4

11.54

11.98

umol/l

0.48

174

1004

Other degenerative diseases of the nervous system

104

403

1.93

8.74

1.4

13.15

12.97

umol/l

0.07

379

Type 2 diabetes, wide definition

348

1562

1.43

8.69

1.4

14.50

12.12

umol/l

6.44

321

1498

Conjunctivitis

372

2222

1.40

8.68

1.4

10.75

11.75

umol/l

2.32

352

2108

Other acute lower respiratory infections

251

1594

1.50

8.68

1.4

12.80

12.17

umol/l

0.84

243

1510

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

124

615

1.80

8.65

1.4

10.07

10.38

umol/l

0.30

118

583

Other nutritional deficiencies

318

2091

1.44

8.64

1.3

1.4

12.74

11.60

umol/l

1.94

283

2002

Dermatitis and eczema

531

2474

1.33

8.63

1.3

1.4

11.65

12.13

umol/l

0.97

498

2351

Streptococcal septicaemia

198

2.55

8.63

1.3

1.4

14.00

12.97

umol/l

0.39

184

Voice disturbances

125

703

1.79

8.62

1.4

12.20

12.48

umol/l

0.18

118

665

Diseases of the musculoskeletal system and connective tissue

302

1026

1.48

8.61

1.4

11.77

11.55

umol/l

0.20

286

965

Phobic anxiety disorders

395

2.06

8.55

1.4

1.5

11.52

11.13

umol/l

0.19

379

Asthma-related infections

273

1820

1.47

8.53

1.3

1.4

12.62

12.00

umol/l

0.75

263

1722

Asthma, hospital admission 2, infections

273

1820

1.47

8.53

1.3

1.4

12.62

12.00

umol/l

0.75

263

1722

Disorders of eyelid, lacrimal system and orbit

387

2125

1.39

8.36

1.4

12.22

12.28

umol/l

0.05

367

2016

Convulsions, not elsewhere classified

110

593

1.84

8.35

1.3

1.5

12.88

11.88

umol/l

0.85

563

Other aneurysm

3.26

8.35

1.4

1.5

11.60

13.65

umol/l

1.21

Injury, poisoning and certain other consequences of external causes

282

951

1.49

8.33

1.4

12.09

11.46

umol/l

0.81

263

908

Cholecystectomy

311

1877

1.43

8.28

1.4

13.24

12.20

umol/l

1.37

294

1783

Chronic hepatitis NAS

7.75

8.23

1.7

1.8

11.50

11.52

umol/l

0.01

Acute bronchitis

182

1123

1.59

8.21

1.4

13.31

12.31

umol/l

1.25

176

1065

Infections of the skin and subcutaneous tissue

290

1996

1.44

8.18

1.4

13.30

11.95

umol/l

2.43

275

1889

Concussion

211

1117

1.54

8.12

1.4

11.37

11.64

umol/l

0.28

204

1065

Other viral diseases

198

1267

1.56

8.07

1.3

1.4

11.33

11.35

umol/l

0.02

189

1217

Solid cancers, helper endpoint

395

1691

1.38

8.07

1.3

1.4

11.62

12.19

umol/l

0.94

382

1604

Retinal detachments and breaks

149

901

1.66

7.95

1.5

1.4

12.40

13.38

umol/l

0.92

139

846

Sleep apnoea

434

2084

1.35

7.83

1.4

12.40

12.19

umol/l

0.27

411

1981

Social phobias

237

2.29

7.50

1.5

10.85

10.99

umol/l

0.07

230

211

1392

1.51

7.49

1.3

1.4

12.28

11.62

umol/l

0.70

204

1326

Hypokalaemia

270

2.20

7.42

1.2

1.5

15.12

13.04

umol/l

0.64

250

Persons with potential health hazards related to communicable diseases

200

1307

1.52

7.41

1.3

1.4

10.89

11.10

umol/l

0.23

187

1255

Implicit fungal Sepsis

148

2.66

7.39

1.4

1.5

15.59

12.97

umol/l

0.92

137

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

166

657

1.61

7.32

1.4

1.3

9.42

9.55

umol/l

0.13

156

635

Asthma-related pneumonia

154

959

1.61

7.28

1.3

1.4

13.94

12.52

umol/l

1.47

149

904

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

100

548

1.81

7.28

1.3

1.5

13.05

13.61

umol/l

0.29

512

Injuries to the hip and thigh

196

1168

1.52

7.24

1.4

15.69

12.71

umol/l

3.53

186

1103

Asthma-related pneumonia or sepsis

154

961

1.60

7.23

1.3

1.4

13.94

12.52

umol/l

1.47

149

906

Asthma, hospital admissions 3, pneumonia

154

961

1.60

7.23

1.3

1.4

13.94

12.52

umol/l

1.47

149

906

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

3.08

7.17

1.6

11.61

15.04

umol/l

2.12

Sequelae of external causes of morbidity and mortality

116

677

1.72

7.12

1.4

13.39

12.65

umol/l

0.41

109

635

Other diseases of pericardium

3.28

7.11

1.4

14.88

12.67

umol/l

0.75

Viral infections characterized by skin and mucous membrane lesions

401

2569

1.34

7.10

1.3

1.4

12.11

11.96

umol/l

0.18

380

2439

Asthma (diagnoses ohter than nonallergic)

402

2499

1.34

7.09

1.3

1.4

12.18

12.01

umol/l

0.18

384

2364

Other obstetric conditions, not elsewhere classified

168

674

1.59

7.07

1.4

1.3

9.48

9.56

umol/l

0.07

157

652

Nontraumatic intracranial haemmorrhage

397

1.95

7.05

1.3

1.5

13.31

13.95

umol/l

0.31

371

Zoster [herpes zoster]

419

1.92

7.01

1.2

1.5

14.78

12.86

umol/l

1.20

397

Diabetes mellitus

484

2164

1.31

7.01

1.4

13.41

11.43

umol/l

7.12

445

2075

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

364

1.99

7.00

1.5

14.44

13.85

umol/l

0.23

346

Other and unspecified immunodeficiencies with predominantly antibody defects

7.71

6.95

1.5

1.9

10.61

10.77

umol/l

0.04

Diabetes, varying definitions

481

2160

1.31

6.91

1.4

13.45

11.43

umol/l

7.34

442

2071

Use of hypnotics and sedatives

495

2184

1.30

6.90

1.4

12.16

umol/l

0.00

464

2083

Obesity, other/unspecified

170

1101

1.55

6.89

1.2

1.4

12.43

11.23

umol/l

1.45

154

1053

Hypo-osmolality and hyponatraemia

357

1.99

6.88

1.4

1.5

14.34

13.43

umol/l

0.41

332

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

125

2.74

6.86

1.6

11.40

14.88

umol/l

2.77

113

Acute upper respiratory infections of multiple and unspecified sites

360

1973

1.35

6.85

1.3

1.4

12.17

11.73

umol/l

0.67

348

1868

Memory loss

172

2.46

6.83

1.3

1.4

13.88

14.50

umol/l

0.20

162

Polyarthropathies

326

1547

1.38

6.80

1.3

1.4

13.66

11.96

umol/l

3.85

300

1475

Fracture of rib(s), sternum and thoracic spine

130

795

1.64

6.72

1.4

14.15

13.28

umol/l

0.65

120

753

Congenital malformations of cardiac chambers and connections

12.76

6.65

1.6

13.00

10.22

umol/l

—

Myocardial infarction, with ST-elevation

364

1.96

6.64

1.4

17.17

14.53

umol/l

1.34

340

Acute upper respiratory infections

477

2267

1.30

6.57

1.4

12.00

12.10

umol/l

0.12

455

2140

Invasive ventilation

176

2.41

6.53

1.3

1.5

14.75

12.84

umol/l

0.68

165

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

259

1797

1.40

6.40

1.4

10.33

11.50

umol/l

2.12

245

1709

Biological medication for rheuma

542

1.76

6.38

1.4

1.5

11.63

11.59

umol/l

0.02

521

Other disorders of lacrimal gland

151

971

1.56

6.36

1.5

1.4

11.37

12.10

umol/l

0.75

145

917

Mycoses

120

732

1.65

6.30

1.5

1.4

13.08

12.47

umol/l

0.41

115

690

Other specific joint derangements/joint disorders

365

1769

1.34

6.24

1.4

11.78

11.67

umol/l

0.12

343

1684

Volume depletion

186

2.32

6.23

1.3

1.5

15.52

14.62

umol/l

0.26

170

Disorders of lens

280

1256

1.39

6.23

1.4

13.45

12.85

umol/l

0.69

261

1199

Bacterial pneumonia (organism specified)

180

1092

1.50

6.23

1.3

1.4

14.30

12.91

umol/l

1.51

170

1027

Fracture of femur

520

1.73

6.21

1.4

17.82

13.41

umol/l

2.76

485

Disorders of ocular muscles, binocular movement, accommodation and refraction

220

1525

1.43

6.15

1.4

10.77

11.54

umol/l

1.13

202

1456

Mixed connective tissue disease

169

2.39

6.13

1.1

1.5

13.15

11.83

umol/l

0.67

158

Gastro-oesophageal reflux disease

289

1822

1.37

6.13

1.3

1.4

12.46

12.15

umol/l

0.32

273

1736

Superficial injury of head

106

631

1.69

6.12

1.5

1.4

13.48

12.37

umol/l

0.78

604

Type 2 diabetes

448

2023

1.30

6.08

1.4

13.38

11.56

umol/l

6.00

412

1941

Allergic conjunctivitis

268

1894

1.38

6.05

1.4

10.38

11.48

umol/l

1.97

254

1801

Other viral diseases

150

973

1.54

6.02

1.4

11.53

11.44

umol/l

0.06

144

930

Benign neoplasm: Colon, unspecified

102

604

1.70

6.02

1.4

13.83

13.47

umol/l

0.19

566

Endometriosis

155

584

1.56

6.01

1.4

10.73

11.11

umol/l

0.29

150

555

Sulfasalazine

122

757

1.62

6.00

1.4

11.31

11.94

umol/l

0.73

117

717

Panic disorder

435

1.82

6.00

1.3

1.5

11.38

11.12

umol/l

0.13

419

Angina pectoris

210

964

1.45

6.00

1.5

1.4

15.25

12.80

umol/l

4.06

194

907

Mycoses

390

2600

1.31

5.99

1.4

12.11

12.01

umol/l

0.11

372

2463

Persons encountering health services in other circumstances

171

1143

1.49

5.90

1.3

1.4

12.48

11.72

umol/l

0.73

163

1089

Sleep apnoea, including avohilmo

449

2162

1.29

5.90

1.4

12.12

12.15

umol/l

0.04

423

2051

Disorders of adult personality and behaviour

146

950

1.54

5.88

1.3

1.4

11.79

11.28

umol/l

0.35

128

917

Dipeptidyl peptidase 4 (DPP-4) inhibitors

213

1191

1.43

5.84

1.3

1.4

15.07

13.06

umol/l

3.48

196

1142

Disorders of lacrimal system

176

1193

1.48

5.75

1.4

11.11

12.13

umol/l

1.46

168

1134

Malignant neoplasm of digestive organs

143

730

1.55

5.71

1.4

1.5

13.05

13.80

umol/l

0.52

134

682

Mental disorders, not otherwise specified

253

2.07

5.70

1.6

1.5

11.90

11.19

umol/l

0.33

242

Soft tissue disorders related to use, overuse and pressure

116

721

1.61

5.70

1.3

1.4

13.17

12.54

umol/l

0.44

110

681

Fungal Sepsis

2.86

5.68

1.4

1.5

14.99

13.89

umol/l

0.26

Congenital malformations of pulmonary and tricuspid valves

13.23

5.62

1.1

1.9

12.22

11.73

umol/l

—

Acute sinusitis

249

1675

1.38

5.57

1.3

1.4

11.51

umol/l

0.00

237

1594

Nonorganic sleeping disorders

103

627

1.65

5.52

1.4

10.78

11.46

umol/l

0.38

596

Symptoms and signs involving the urinary system

315

1804

1.33

5.51

1.3

1.4

13.44

12.52

umol/l

1.47

297

1710

Livedoid vasculitis

16.85

5.48

1.3

1.2

16.37

13.00

umol/l

—

Insulin, intermediate and long-acting

228

1595

1.39

5.44

1.4

14.14

12.62

umol/l

2.30

209

1515

Non-selective monoamine reuptake inhibitors

148

949

1.51

5.38

1.4

12.79

umol/l

0.00

138

906

Injuries to the thorax

187

1304

1.44

5.36

1.4

13.23

12.88

umol/l

0.27

175

1235

Secondary hypertension

141

2.39

5.30

1.3

1.5

17.78

11.91

umol/l

2.23

135

Cutaneous abscess, furuncle and carbuncle

122

783

1.56

5.27

1.6

1.4

12.35

12.14

umol/l

0.14

115

748

Agranulocytosis

296

1.94

5.24

1.4

1.5

12.59

12.30

umol/l

0.11

277

Genitourinary diseases

284

1052

1.36

5.21

1.4

13.37

11.73

umol/l

2.86

268

997

Aortic aneurysm

512

1.69

5.20

1.4

13.85

14.33

umol/l

0.20

476

Implicit fungal Sepsis

2.82

5.15

1.5

14.78

13.73

umol/l

0.23

Triptan medication for migraine, single purchase ok

371

1950

1.29

5.10

1.4

10.41

11.64

umol/l

3.45

353

1860

Migraine, single triptan purchase ok & required. ICD-code if available is included

371

1950

1.29

5.10

1.4

10.41

11.64

umol/l

3.45

353

1860

Personality disorders

135

894

1.52

5.08

1.3

1.4

11.92

11.27

umol/l

0.44

118

861

Status post-ami

414

1.68

5.06

1.5

1.4

16.70

14.00

umol/l

2.43

381

Type 2 diabetes, definitions combined

413

1904

1.27

5.05

1.4

13.75

11.66

umol/l

7.25

383

1830

Gastroduodenal ulcer

587

1.64

5.03

1.4

13.79

13.91

umol/l

0.05

550

Inflammatory diseases of female pelvic organs

258

1404

1.35

5.02

1.4

1.3

10.34

10.92

umol/l

0.79

249

1339

Cellulitis

103

644

1.61

5.00

1.4

13.59

12.52

umol/l

0.77

613

Hernia

416

2201

1.27

4.99

1.4

13.27

12.10

umol/l

2.67

393

2087

Type 2 diabetes, strict (exclude DM1)

415

1918

1.27

4.98

1.4

13.76

11.67

umol/l

7.28

384

1842

Asthma, hospital admissions , main diagnosis only

366

2525

1.28

4.93

1.3

1.4

12.05

11.96

umol/l

0.10

352

2388

Diseases of the respiratory system

304

1148

1.33

4.91

1.4

12.48

11.53

umol/l

1.43

286

1088

Osteoporosis with pathological fracture (FG)

136

2.37

4.90

1.5

1.6

12.60

12.25

umol/l

0.09

127

Finngen Rheumatological endpoints

449

2034

1.26

4.87

1.4

12.44

11.72

umol/l

1.42

429

1937

Dermatitis

261

1952

1.33

4.85

1.3

1.4

12.20

12.21

umol/l

0.01

245

1853

Systemic disorders of connective tissue in diseases classified elsewhere

12.00

4.84

1.4

1.1

14.85

14.29

umol/l

—

Other disorders of kidney and ureter

319

1.86

4.83

1.4

1.5

16.82

13.42

umol/l

1.57

300

Irregular menses

212

1214

1.38

4.77

1.3

10.43

10.32

umol/l

0.10

201

1163

Asthma, including avohilmo

540

2471

1.23

4.77

1.3

1.4

12.36

11.96

umol/l

0.58

516

2342

Myelodysplastic syndrome, including Hilmo

3.30

4.76

1.2

1.6

12.22

14.42

umol/l

0.61

Neuromuscular dysfunction of bladder

237

2.00

4.73

1.5

1.4

12.02

12.61

umol/l

0.24

222

Cholecystitis

303

1.86

4.59

1.7

1.4

13.56

umol/l

0.00

281

Disorders of choroid and retina

320

1760

1.29

4.58

1.4

13.13

12.76

umol/l

0.40

301

1668

Other and unspecified disorders of binocular movement

10.33

4.56

1.0

1.6

11.61

10.88

umol/l

—

Polyuria

551

1.62

4.54

1.4

12.98

13.23

umol/l

0.14

516

Gingivitis and periodontal diseases

461

1914

1.24

4.53

1.4

12.43

11.88

umol/l

0.96

427

1820

Chronic lower respiratory diseases

555

2427

1.22

4.52

1.3

1.4

12.69

11.79

umol/l

2.00

526

2303

Fracture of lumbar spine and pelvis

512

1.64

4.52

1.4

1.5

13.57

13.03

umol/l

0.32

482

Sequelae with surgical and medical care as external cause

507

1.64

4.47

1.5

13.99

12.91

umol/l

0.47

475

Post-traumatic stress disorder

222

1.99

4.45

1.2

1.4

10.71

10.43

umol/l

0.13

211

Cramp and spasm

130

2.33

4.44

1.6

1.5

12.20

12.75

umol/l

0.20

123

Obesity and other hyperalimentation

278

2057

1.30

4.41

1.3

1.4

12.94

11.56

umol/l

2.41

254

1965

Other disorders of eyelid

161

1081

1.42

4.41

1.4

13.42

13.19

umol/l

0.16

152

1016

Cervicalgia

571

1.60

4.40

1.3

1.5

11.76

11.93

umol/l

0.10

535

Senile cataract

237

1080

1.35

4.40

1.4

13.95

13.06

umol/l

1.06

219

1029

Insulin, combination of fast acting with intermediate-acting or long-acting

250

1728

1.32

4.40

1.4

14.25

12.55

umol/l

2.96

230

1644

Complex cardiac defects

7.76

4.40

1.2

1.5

13.67

10.33

umol/l

—

Acute tubulo-interstitial nephritis

244

1586

1.33

4.38

1.5

1.4

14.06

11.60

umol/l

5.06

230

1496

Unspecified haematuria

157

912

1.43

4.38

1.4

14.69

13.43

umol/l

1.32

146

859

Behavioural syndromes associated with physiological disturbances and physical factors

418

2384

1.24

4.37

1.3

1.4

11.05

12.02

umol/l

2.17

396

2262

Open wound of head

224

1611

1.34

4.36

1.5

1.4

14.36

12.57

umol/l

2.34

211

1528

Vitamin deficiency

119

2.37

4.33

1.4

1.5

16.36

12.41

umol/l

1.08

111

Vitamin deficiency, wide

119

2.37

4.33

1.4

1.5

16.35

12.41

umol/l

1.08

111

Other and unspecified dermatitis

217

1620

1.34

4.25

1.3

1.4

12.03

12.19

umol/l

0.13

204

1541

Conjunctivitis (acute, non atopic)

124

837

1.48

4.25

1.3

1.4

11.45

11.84

umol/l

0.33

118

798

Use of anticholinesterases

103

525

1.55

4.24

1.7

1.4

14.62

14.82

umol/l

0.09

490

N06DA Anticholinesterases

103

525

1.55

4.24

1.7

1.4

14.62

14.82

umol/l

0.09

490

Other symptoms and signs involving the nervous and musculoskeletal systems

174

1255

1.39

4.23

1.3

1.4

12.24

11.83

umol/l

0.33

160

1193

Injuries to the ankle and foot

324

2269

1.27

4.19

1.3

1.4

11.83

11.53

umol/l

0.36

306

2161

Lymphangioma, anys site

7.10

4.19

1.0

1.5

8.86

9.80

umol/l

—

Other diseases of pleura

159

990

1.41

4.16

1.5

1.4

14.49

13.86

umol/l

0.41

150

929

Obesity

275

2053

1.29

4.16

1.3

1.4

12.99

11.56

umol/l

2.53

252

1961

Infections with a predominantly sexual mode of transmission

145

1016

1.43

4.15

1.4

11.46

10.66

umol/l

0.70

136

971

Candidiasis

122

829

1.48

4.13

1.3

1.4

11.96

11.65

umol/l

0.18

113

784

Insulin medication

250

1604

1.31

4.13

1.4

14.25

12.19

umol/l

4.07

230

1541

Injuries to the abdomen, lower back, lumbar spine and pelvis

157

1106

1.41

4.12

1.4

13.22

12.41

umol/l

0.68

147

1047

Acute myeloid leukaemia and myelodysplastic syndromes

4.05

4.11

1.1

1.9

16.31

15.01

umol/l

0.17

Disorders of sclera, cornea, iris and ciliary body

232

1759

1.32

4.10

1.4

12.34

12.08

umol/l

0.24

219

1671

Myocardial infarction, without ST-elevation

134

846

1.45

4.06

1.4

16.30

14.23

umol/l

1.84

123

790

Arteriovenous malformation of peripheral vessels

10.32

4.04

1.4

1.6

8.71

11.14

umol/l

—

Type 2 diabetes, definitions combined, including avohilmo

409

1923

1.24

4.04

1.4

13.70

11.63

umol/l

6.95

378

1851

Congenital stenosis of pulmonary valve

10.23

4.03

1.0

1.3

14.86

10.29

umol/l

—

Noninflammatory disorders of female genital tract

180

649

1.39

4.03

1.5

1.4

10.63

10.98

umol/l

0.26

168

620

Secondary thrombocytopenia

5.10

4.02

1.5

1.9

12.27

12.65

umol/l

0.08

Right ventricular outflow tract obstruction

6.59

4.01

1.1

1.6

12.78

10.72

umol/l

—

Unspecific neurodegenerative disorder

124

575

1.48

4.00

1.6

1.4

14.46

14.95

umol/l

0.26

114

535

Atrophic disorders of skin

377

1.70

4.00

1.5

9.56

11.66

umol/l

3.12

359

Fissure and fistula of anal and rectal regions

642

1.53

3.97

1.4

12.45

12.34

umol/l

0.05

610

Insulin, fast-acting

148

1053

1.41

3.93

1.4

13.24

12.38

umol/l

0.74

138

1000

Chronic sinusitis

183

1349

1.36

3.91

1.2

1.4

11.65

11.99

umol/l

0.24

172

1282

Infections with a predominantly sexual mode of transmission

186

1282

1.35

3.87

1.3

1.4

11.47

10.75

umol/l

0.68

174

1224

Other hereditary haemolytic anaemias

8.98

3.80

2.6

1.8

11.86

9.50

umol/l

—

Defects in the complement system

8.95

3.79

1.7

1.6

11.10

9.63

umol/l

—

Substance abuse, excluding more controls

222

1440

1.32

3.78

1.3

1.4

13.76

12.34

umol/l

1.65

186

1384

Disorders of vitreous body and globe

188

1346

1.34

3.75

1.4

12.20

13.01

umol/l

0.80

178

1269

Low back pain

333

1915

1.25

3.70

1.4

13.32

11.89

umol/l

2.63

318

1818

Specific personality disorders

113

776

1.46

3.68

1.3

1.4

11.94

11.29

umol/l

0.36

748

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

175

1290

1.35

3.68

1.2

1.4

11.87

11.15

umol/l

0.73

170

1231

Epilepsy

119

823

1.44

3.67

1.3

1.4

12.36

12.41

umol/l

0.02

109

786

Other specified/unspecified systemic involvement of connective tissue

149

2.10

3.63

1.1

1.5

13.11

11.78

umol/l

0.55

140

Caries of enamel

398

2350

1.22

3.63

1.4

11.04

11.91

umol/l

2.33

374

2232

Other and unspecified disorders of vitreous body

152

1090

1.38

3.59

1.4

11.74

13.01

umol/l

1.51

146

1035

Disorders of vitreous body

183

1323

1.34

3.58

1.4

12.21

13.00

umol/l

0.75

175

1247

Allergic colitis

2.97

3.57

1.7

1.8

10.19

9.90

umol/l

0.08

Other (seronegative) rheumatoid arthritis, wide

460

1.59

3.55

1.3

1.5

13.03

12.68

umol/l

0.13

437

Drug-induced systemic lupus erythematosus

6.32

3.53

1.5

1.8

13.56

12.45

umol/l

—

Intestinal adhesions without obstruction

178

1.98

3.53

1.3

1.4

13.82

12.33

umol/l

0.85

166

Rheumatoid arthritis

126

798

1.42

3.50

1.3

1.4

12.13

12.39

umol/l

0.16

118

759

Paralytic ileus

2.55

3.47

1.7

1.5

12.73

13.07

umol/l

0.09

Other spirochaetal diseases

124

878

1.42

3.45

1.3

1.4

10.84

12.49

umol/l

2.86

118

831

Melanocytic naevi

126

895

1.41

3.45

1.2

1.4

11.18

11.82

umol/l

0.54

121

853

Insulin, fast-acting or short human

149

1089

1.37

3.43

1.4

13.25

12.50

umol/l

0.62

139

1032

Intracranial injury

235

1733

1.28

3.42

1.4

11.81

12.04

umol/l

0.27

224

1640

Seborrhoeic keratosis

504

1.55

3.42

1.5

1.4

12.70

12.86

umol/l

0.08

474

Scoliosis

230

1.83

3.41

1.4

1.5

11.89

11.48

umol/l

0.13

215

Zoster [herpes zoster]

183

1360

1.33

3.40

1.3

1.4

13.11

12.65

umol/l

0.37

174

1291

Heartburn

252

1.79

3.40

1.3

1.4

13.62

12.20

umol/l

0.54

237

Disorders of skin appendages

208

1598

1.30

3.40

1.4

11.87

11.60

umol/l

0.27

194

1520

Erosion of teeth , including avohilmo

113

790

1.43

3.38

1.4

11.09

11.49

umol/l

0.35

104

752

Rheumatoid arthritis, including avohilmo

144

1051

1.37

3.36

1.3

1.4

12.21

12.40

umol/l

0.12

135

1000

Herpesviral [herpes simplex] infections

105

725

1.45

3.36

1.3

1.4

11.04

11.09

umol/l

0.03

694

Other and unspecified injuries of head

168

1.97

3.33

1.3

1.5

14.44

12.58

umol/l

0.74

161

Fracture of skull and facial bones

612

1.49

3.33

1.5

12.79

12.48

umol/l

0.18

586

Other extrapyramidal and movement disorders in other diseases

588

1.50

3.32

1.2

1.4

13.13

12.54

umol/l

0.31

549

Adverse effects, not elsewhere classified

572

1.51

3.32

1.3

1.4

11.06

11.52

umol/l

0.32

547

Unstable angina pectoris

117

650

1.42

3.26

1.5

1.4

14.24

13.58

umol/l

0.48

105

604

Temporomandibular joint disorders, including avohilmo

191

1442

1.31

3.24

1.3

1.4

10.08

11.11

umol/l

2.40

182

1378

Diseases of oral cavity, salivary glands and jaws

252

1016

1.28

3.23

1.4

13.11

12.36

umol/l

0.87

236

969

Other and unspecified effects of external causes

122

873

1.40

3.23

1.3

1.4

11.08

11.66

umol/l

0.58

113

834

Other spirochaetal diseases

121

865

1.40

3.22

1.3

1.4

10.76

12.52

umol/l

3.22

115

818

Abnormal findings on diagnostic imaging of lung

167

1204

1.33

3.20

1.4

14.62

13.36

umol/l

1.18

157

1134

Nerve, nerve root and plexus disorders

450

2309

1.19

3.20

1.3

1.4

12.72

12.10

umol/l

1.06

423

2200

Diseases of inner ear

199

1486

1.30

3.17

1.4

12.60

12.64

umol/l

0.02

186

1410

Other/unspecified dorsalgia

152

1121

1.35

3.16

1.3

1.4

12.64

11.79

umol/l

0.74

147

1060

Injuries to the elbow and forearm

297

2113

1.24

3.16

1.4

12.54

11.99

umol/l

0.61

285

1995

Schizophrenia or delusion, excluding more controls

122

868

1.39

3.15

1.2

1.4

12.19

11.92

umol/l

0.15

842

Other noninfective disorders of lymphatic vessels and lymph nodes

2.42

3.14

1.6

1.5

10.50

12.33

umol/l

0.68

Spirochaetal infections, other/unspecified

120

861

1.40

3.14

1.3

1.4

10.84

12.51

umol/l

2.84

114

815

Disorders of vestibular function (Vertigo)

171

1277

1.32

3.10

1.4

12.68

12.57

umol/l

0.06

159

1210

Other sleep disorders

283

1.70

3.07

1.2

1.5

12.37

12.68

umol/l

0.10

265

Lyme disease

119

856

1.39

3.07

1.3

1.4

10.72

12.49

umol/l

3.22

113

810

Other and unspecified myopathies

202

1.84

3.07

1.1

1.5

16.15

14.23

umol/l

0.52

189

Other and unspecified disorders of white blood cells

2.24

3.06

1.1

1.5

13.89

13.58

umol/l

0.05

Diseases of salivary glands

128

935

1.37

3.02

1.2

1.4

13.32

11.94

umol/l

1.14

119

891

Other forms of systemic lupus erythematosus

4.38

3.01

1.2

1.7

12.86

11.84

umol/l

—

Eclampsia

10.45

3.01

1.0

1.8

11.38

10.40

umol/l

—

Thyrotoxicosis factitia

10.37

3.00

2.0

1.2

6.28

10.20

umol/l

—

Scar conditions and fibrosis of skin

100

2.22

3.00

1.5

8.72

11.23

umol/l

1.72

Retention of urine

116

682

1.40

2.99

1.3

1.4

14.39

13.67

umol/l

0.47

108

637

Triptan medication for migraine, min. 3 purchases

251

1529

1.25

2.99

1.4

9.78

10.95

umol/l

3.21

239

1467

Malignant neoplasm of breast, HER2-negative, including Hilmo

162

789

1.33

2.97

1.3

1.4

11.28

umol/l

0.00

157

747

Malignant neoplasm of breast, including Hilmo

162

789

1.33

2.97

1.3

1.4

11.28

umol/l

0.00

157

747

Malignant neoplasm of colon, including Hilmo

394

1.58

2.96

1.4

1.5

14.34

14.23

umol/l

0.03

366

Menorrhagia

135

546

1.37

2.95

1.5

1.4

10.23

11.20

umol/l

1.00

128

520

Other cataract

157

894

1.33

2.95

1.3

1.4

14.25

12.97

umol/l

1.11

142

849

Lung transplant status

4.82

2.94

1.4

1.7

12.12

10.88

umol/l

—

Lung transplantation

4.81

2.94

1.4

1.7

12.13

10.88

umol/l

—

Allergic asthma (mode), excluding more controls

100

690

1.42

2.91

1.4

10.02

10.47

umol/l

0.35

653

Malignant neoplasm of breast

157

771

1.33

2.88

1.3

1.4

11.00

11.31

umol/l

0.22

152

731

Fall on and from stairs and steps

100

707

1.42

2.88

1.3

1.4

13.82

12.55

umol/l

0.82

667

Pain and other conditions associated with female genital organs and menstrual cycle

528

1.47

2.85

1.3

1.4

10.11

10.45

umol/l

0.19

505

Polyp of the female genital tract

117

482

1.40

2.85

1.4

10.53

11.36

umol/l

0.75

111

459

Malignant neoplasm of breast, HER2-negative

154

758

1.33

2.85

1.3

1.4

10.95

11.34

umol/l

0.28

149

718

Ovarian cyst

141

603

1.35

2.81

1.4

10.88

11.09

umol/l

0.14

130

574

Herpesviral [herpes simplex] infections

314

1.63

2.81

1.4

1.5

11.76

11.71

umol/l

0.02

300

Chronic apical periodontitis

486

2364

1.17

2.78

1.3

1.4

12.92

11.87

umol/l

2.72

452

2244

Other congenital malformations of kidney

8.56

2.77

1.6

1.0

8.86

11.00

umol/l

—

Maternal care for other conditions predominantly related to pregnancy

674

1.41

2.76

1.3

9.21

9.74

umol/l

0.77

650

Exclusions for E4_PCOS_CONSORTIUM

307

1579

1.22

2.76

1.3

1.4

10.99

11.24

umol/l

0.25

285

1517

Other diseases of hard tissues of teeth

244

1009

1.25

2.73

1.4

12.11

12.31

umol/l

0.18

227

962

Dorsalgia

437

1985

1.18

2.71

1.3

1.4

12.20

11.91

umol/l

0.40

413

1879

Other diseases of upper respiratory tract

472

2099

1.17

2.71

1.3

1.4

12.02

12.36

umol/l

0.45

448

1986

Presence of other functional implants

192

1042

1.28

2.70

1.3

1.4

12.68

13.11

umol/l

0.37

183

977

Unspecified fall

193

1498

1.27

2.70

1.4

13.18

12.39

umol/l

0.70

181

1420

Complications of other internal prosthetic devices, implants and grafts

2.34

2.65

1.6

1.5

12.08

13.25

umol/l

0.29

Exposure to other specified factors

323

2471

1.20

2.65

1.3

1.4

11.81

11.87

umol/l

0.05

305

2346

Other specified/unspecified bacterial intestinal infections

169

1.84

2.63

1.7

1.5

13.88

12.74

umol/l

0.36

159

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.22

2.62

1.2

1.7

11.10

10.49

umol/l

0.16

Whooping cough

3.38

2.61

1.5

10.68

10.07

umol/l

—

Diseases of the ear and mastoid process

522

2260

1.16

2.61

1.4

11.44

12.11

umol/l

1.54

491

2147

Injuries to the knee and lower leg

515

2468

1.16

2.58

1.3

1.4

11.98

12.06

umol/l

0.10

482

2347

Polycystic ovarian syndrome, consortium definition

287

1397

1.22

2.58

1.4

1.3

10.78

10.83

umol/l

0.05

273

1337

Multiple myeloma, including Hilmo

2.20

2.57

1.3

1.7

16.78

13.62

umol/l

0.70

Multiple myeloma and malignant plasma cell neoplasms

2.20

2.57

1.3

1.5

16.78

14.91

umol/l

0.35

Other symptoms and signs involving the circulatory and respiratory systems

163

1.85

2.57

1.5

12.77

12.07

umol/l

0.19

153

Other dorsopathies, not elsewhere classified

447

1998

1.17

2.56

1.4

12.30

11.90

umol/l

0.61

428

1890

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

392

2001

1.18

2.54

1.3

1.4

13.87

11.61

umol/l

7.11

358

1920

Colonic or urogenital fistula

105

768

1.37

2.52

1.4

12.61

12.57

umol/l

0.02

728

Benign neoplasm: Rectum, anus and anal canal

484

1.47

2.52

1.5

13.53

13.77

umol/l

0.09

457

Non-Hodgkin lymphoma, all

2.28

2.51

1.1

1.6

16.05

14.68

umol/l

0.34

Infarction of spleen

4.48

2.49

1.3

1.9

12.26

12.19

umol/l

—

Female infertility

119

534

1.36

2.49

1.5

1.4

10.14

10.86

umol/l

0.66

113

510

Hypoparathyroidism

2.33

2.49

1.6

11.20

12.20

umol/l

0.37

Migraine without aura, drug-induced

3.86

2.47

1.1

1.7

9.03

10.80

umol/l

—

Hepatocellular carcinoma, including Hilmo

2.47

2.45

1.5

1.8

12.28

14.63

umol/l

0.68

Fracture of forearm

217

1607

1.24

2.44

1.4

12.38

12.02

umol/l

0.27

208

1516

Disorders of refraction and accommodation

114

847

1.34

2.43

1.4

11.10

11.50

umol/l

0.28

105

811

Sleep disorders

379

2330

1.18

2.42

1.3

1.4

11.22

12.00

umol/l

1.42

360

2210

Melanoma in situ of lower limb, including hip

5.10

2.41

1.8

9.53

13.33

umol/l

—

Scarlet fever

5.07

2.41

1.2

1.3

6.60

8.70

umol/l

—

Lymphoid leukaemia

110

2.01

2.41

1.5

1.6

11.87

14.40

umol/l

1.11

104

Postmenopausal osteoporosis with pathological fracture

110

2.01

2.41

1.5

1.6

12.96

12.77

umol/l

0.04

103

Glomerular disorders in diseases classified elsewhere

304

1.58

2.40

1.4

19.79

13.36

umol/l

3.10

283

Early onset COPD, excluding more controls

465

1.46

2.39

1.4

15.47

12.67

umol/l

1.53

441

Atrioventricular septal defect

6.42

2.39

1.0

1.4

9.80

9.75

umol/l

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.40

2.39

1.0

1.7

8.80

8.50

umol/l

—

Arthropathies

420

1820

1.17

2.38

1.4

12.22

11.70

umol/l

0.78

398

1730

Other diseases of gallbladder

2.07

2.37

1.5

13.79

13.31

umol/l

0.13

Other retinal disorders

221

1397

1.23

2.37

1.3

1.4

13.40

13.01

umol/l

0.34

207

1316

Other diseases of arteries and capillaries

205

1.71

2.37

1.3

1.5

10.83

12.88

umol/l

1.44

191

Left ventricular outflow tract obstruction, narrow definition

139

1.88

2.36

1.3

1.6

12.23

12.65

umol/l

0.12

133

Malignant neoplasm of liver and intrahepatic bile ducts

2.52

2.36

1.8

1.6

10.61

14.64

umol/l

1.63

Demyelinating diseases of the central nervous system

251

1.64

2.36

1.3

1.5

12.57

11.23

umol/l

0.60

235

Allergic asthma (mode)

100

719

1.36

2.36

1.4

10.02

10.85

umol/l

0.79

681

Anosmia

3.06

2.36

1.4

12.33

9.74

umol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

125

1.93

2.35

1.4

9.72

10.03

umol/l

0.14

115

Excessive, frequent and irregular menstruation

151

638

1.30

2.34

1.5

1.4

10.30

11.00

umol/l

0.76

143

609

Spondylosis

202

1326

1.24

2.34

1.3

1.4

13.37

12.68

umol/l

0.70

191

1254

Dermatophytosis

245

2017

1.21

2.34

1.4

12.13

12.08

umol/l

0.05

237

1901

Keratitis

138

1065

1.30

2.33

1.4

12.75

12.11

umol/l

0.57

130

1019

In situ neoplasms

129

987

1.31

2.32

1.6

1.4

13.73

12.44

umol/l

1.07

123

927

Delirium, not induced by alcohol and other psychoactive substances

221

1.68

2.32

1.4

15.89

14.59

umol/l

0.45

206

Sacrococcygeal disorders, not elsewhere classified

2.20

2.31

1.5

1.4

13.45

11.14

umol/l

0.53

Type 1 diabetes

101

746

1.35

2.30

1.4

12.58

11.49

umol/l

0.76

719

COPD (mode)

551

1.37

2.28

1.3

1.5

17.24

13.00

umol/l

3.31

520

Unspecified mental disorder

167

1325

1.26

2.27

1.4

12.34

11.67

umol/l

0.56

127

1273

Gastric ulcer

397

1.49

2.27

1.4

1.5

13.60

13.84

umol/l

0.08

370

Striking against or struck by other objects

142

1104

1.29

2.26

1.3

1.4

11.35

11.96

umol/l

0.72

132

1044

Social disorders starting during childhood or adolecense, excluding more controls

3.95

2.26

1.6

1.7

11.14

8.65

umol/l

—

Social disorders starting during childhood or adolescence

3.95

2.26

1.6

1.9

11.14

9.69

umol/l

—

Rheumatism, unspecified

317

1.55

2.26

1.3

1.4

11.20

11.48

umol/l

0.10

301

Thyroiditis

186

1.73

2.24

1.7

1.5

10.55

11.27

umol/l

0.28

175

Hypersomnia

3.14

2.23

1.0

1.7

13.90

11.83

umol/l

—

Other and unspecified papulosquamous disorders

5.65

2.22

1.0

1.6

16.02

13.90

umol/l

—

Abnormal spermatozoa

285

0.45

2.22

1.4

13.61

15.16

umol/l

0.59

266

Spondylopathies

310

1560

1.19

2.20

1.4

13.04

12.39

umol/l

0.90

295

1483

Atopic dermatitis

254

1730

1.20

2.19

1.4

10.79

11.22

umol/l

0.62

238

1649

Multiple myeloma

2.52

2.19

1.3

1.7

16.15

15.06

umol/l

0.13

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.52

2.19

1.3

1.7

16.15

15.06

umol/l

0.13

Haemorrhoids and perianal venous thrombosis

105

786

1.33

2.19

1.4

12.56

12.82

umol/l

0.14

741

Diabetes medication

441

2267

1.15

2.19

1.4

13.44

11.65

umol/l

5.16

404

2172

Convergence insufficiency and excess

3.37

2.18

1.4

1.5

10.00

10.40

umol/l

—

Malignant neoplasm of colon

304

1.55

2.18

1.4

1.5

14.48

13.92

umol/l

0.12

282

Urticaria and erythema

149

1174

1.27

2.17

1.4

11.19

11.49

umol/l

0.21

141

1117

Disorders of breast

185

1355

1.24

2.17

1.5

1.3

9.62

11.11

umol/l

3.77

177

1293

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

4.37

2.16

1.2

1.9

11.17

12.56

umol/l

—

Fibrosis of liver

4.36

2.16

1.3

1.6

9.17

12.43

umol/l

—

Paracetamol or NSAID medication

293

1.41

2.16

1.5

1.4

12.40

12.22

umol/l

0.07

273

Autoimmune thyroiditis

2.80

2.14

1.7

1.6

10.26

10.90

umol/l

—

Other specified disorders of kidney and ureter

2.11

2.13

1.4

1.5

12.87

13.28

umol/l

0.08

Degenerative macular diseases

243

1.61

2.12

1.3

1.5

13.87

13.76

umol/l

0.03

228

Diseases of external ear

127

984

1.29

2.12

1.3

1.4

12.17

12.38

umol/l

0.15

114

938

Cyst of kidney

152

1.78

2.12

1.4

15.83

14.12

umol/l

0.40

142

Testicular dysfunction

102

1.97

2.11

1.6

1.5

14.05

13.75

umol/l

0.05

Type 1 diabetes, wide definition, subgroup 1

613

1.37

2.10

1.4

12.59

11.32

umol/l

0.81

588

Other and unspecified nonorganic psychotic disorders

614

1.37

2.09

1.2

1.5

11.73

11.50

umol/l

0.10

592

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

5.10

2.08

1.2

1.8

10.00

12.90

umol/l

—

Periodontitis

391

2260

1.16

2.08

1.3

1.4

14.08

11.99

umol/l

6.20

362

2154

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

120

915

1.30

2.07

1.5

1.4

9.93

10.71

umol/l

1.06

112

878

Dystonia

146

1.79

2.06

1.4

1.3

11.00

11.85

umol/l

0.27

139

Dorsopathies

454

2012

1.15

2.05

1.4

12.16

11.86

umol/l

0.42

437

1904

Selective deficiency of immunoglobulin G [IgG] subclasses

4.07

2.05

2.2

2.0

9.12

10.39

umol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

4.06

2.05

1.2

2.1

8.43

10.53

umol/l

—

Unequal limb length (acquired)

4.05

2.04

1.3

1.9

12.17

10.69

umol/l

—

Strabismus

105

796

1.32

2.03

1.5

1.4

10.91

11.81

umol/l

0.80

759

Seropositive rheumatoid arthritis

650

1.35

2.01

1.3

1.4

11.96

12.24

umol/l

0.16

611

Tinnitus

653

1.35

2.01

1.5

12.28

12.51

umol/l

0.08

615

Benign paroxysmal vertigo

749

1.32

1.99

1.4

12.47

12.64

umol/l

0.08

708

Shoulder lesions

296

1521

1.18

1.98

1.4

12.28

12.47

umol/l

0.20

280

1444

Drug-induced neutropenia

186

1.67

1.97

1.4

1.5

13.21

12.24

umol/l

0.31

177

Chronic periodontitis, including avohilmo

388

2257

1.15

1.97

1.3

1.4

14.12

11.98

umol/l

6.36

359

2151

Dialysis

1.99

1.95

1.6

17.71

12.50

umol/l

1.64

Right side

4.64

1.95

1.4

2.4

12.79

14.28

umol/l

—

Malignant neoplasm of ovary

1.95

1.5

1.6

10.18

11.68

umol/l

0.67

Lower back pain or/and sciatica

437

2499

1.14

1.95

1.4

12.88

11.97

umol/l

1.71

415

2374

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

188

1.66

1.90

1.3

1.5

10.50

11.40

umol/l

0.43

177

Lifestyle-related condition

3.22

1.88

1.3

1.7

18.81

11.50

umol/l

—

Dentofacial anomalies [including malocclusion]

297

2043

1.17

1.86

1.3

1.4

10.39

11.45

umol/l

2.91

282

1943

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

106

815

1.30

1.86

1.2

1.4

10.77

11.53

umol/l

0.47

795

Methotrexate

333

1.47

1.85

1.1

1.5

14.75

12.08

umol/l

1.54

315

Degeneration of macula and posterior pole

141

898

1.25

1.81

1.3

1.4

13.93

13.95

umol/l

0.01

129

841

Other factor of the environment

3.07

1.80

1.3

1.8

18.81

11.96

umol/l

—

Calculus of kidney and ureter

106

823

1.29

1.80

1.4

14.55

13.31

umol/l

0.76

775

Urolithiasis

112

876

1.28

1.79

1.4

14.53

13.30

umol/l

0.80

103

824

Atopic dermatitis, strict definition with reimbursement

130

1000

1.26

1.78

1.4

10.89

10.95

umol/l

0.04

124

962

Seropositive rheumatoid arthritis, wide

667

1.32

1.78

1.3

1.4

11.96

12.71

umol/l

0.53

630

Hernia of abdominal wall

164

1342

1.22

1.77

1.2

1.4

13.65

12.71

umol/l

0.88

158

1268

Other arthrosis

203

1170

1.20

1.77

1.4

12.17

12.65

umol/l

0.47

189

1116

Thiazolidinediones

264

1.52

1.75

1.3

1.5

15.93

13.51

umol/l

0.75

255

Disorders resulting from impaired renal tubular function

2.04

1.75

1.5

1.6

23.40

13.40

umol/l

1.59

Other specified/unspecified arthritis

103

800

1.29

1.75

1.3

1.4

12.66

12.02

umol/l

0.55

763

Benign neoplasm: Sigmoid colon

456

1.38

1.72

1.3

1.5

14.02

13.57

umol/l

0.16

432

Disorders of plasma-protein metabolism, not elsewhere classified

3.90

1.72

1.8

1.7

10.32

10.23

umol/l

—

Prophylactic surgery

3.89

1.72

1.0

1.8

8.24

9.67

umol/l

—

Varicella [chickenpox]

125

1.77

1.72

1.3

1.6

11.89

12.28

umol/l

0.13

117

Bipolar affective disorders

585

1.34

1.71

1.3

1.5

11.76

11.37

umol/l

0.24

564

Contact with and exposure to communicable diseases

134

1074

1.24

1.70

1.3

1.4

10.39

10.79

umol/l

0.43

125

1037

Panniculitis affecting regions of neck and back

1.92

1.70

1.5

14.36

11.79

umol/l

0.54

Other disorders of bone

578

1.33

1.68

1.5

1.4

12.60

11.96

umol/l

0.30

550

Other strabismus

671

1.31

1.68

1.5

1.4

10.95

11.53

umol/l

0.38

642

Diabetes, insulin treatment (Kela reimbursement)

410

2185

1.13

1.67

1.4

13.89

11.88

umol/l

6.05

376

2093

Chronic periodontitis, complicated

197

1638

1.19

1.66

1.3

1.4

14.52

12.55

umol/l

3.54

180

1556

MS-disease / Multiple Sclerosis

204

1.57

1.65

1.3

1.5

12.43

11.07

umol/l

0.49

189

Hepatocellular carcinoma

2.46

1.64

1.5

1.7

13.40

15.31

umol/l

—

Viral warts

650

1.31

1.64

1.4

1.5

11.49

11.46

umol/l

0.02

621

Obesity due to excess calories

186

1558

1.20

1.61

1.3

1.4

13.51

11.43

umol/l

3.31

173

1485

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

203

1665

1.19

1.60

1.4

11.87

12.24

umol/l

0.33

197

1578

Alcohol abuse, main dg, excluding more controls

403

1.39

1.60

1.1

1.5

14.23

12.97

umol/l

0.51

391

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

262

1.49

1.60

1.5

13.65

12.61

umol/l

0.38

243

Insomnia

363

2327

1.14

1.60

1.3

1.4

11.15

11.89

umol/l

1.27

347

2207

Other obstructed labour

210

0.47

1.59

1.1

1.4

8.98

10.53

umol/l

—

201

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.96

1.59

1.5

1.6

11.35

12.13

umol/l

0.21

Dental operations

255

1120

1.17

1.59

1.4

13.02

12.33

umol/l

0.79

240

1060

Otitis externa

646

1.30

1.57

1.1

1.4

11.94

12.26

umol/l

0.19

618

Non-Hodgkin lymphoma, all, including Hilmo

288

1.46

1.56

1.3

1.5

15.19

13.72

umol/l

0.72

267

Toxic effects of substances chiefly nonmedicinal as to source

338

1.42

1.56

1.2

1.5

13.25

11.87

umol/l

0.67

318

Otorrhagia

3.38

1.53

1.4

1.7

17.42

13.19

umol/l

—

Other and unspecified nonscarring hair loss

3.38

1.53

2.8

1.6

9.30

10.11

umol/l

—

Fracture of shoulder and upper arm

126

1021

1.23

1.53

1.2

1.4

13.83

12.47

umol/l

1.15

117

964

Pleural plaque with presence of asbestos

142

0.42

1.52

1.5

13.10

16.70

umol/l

—

129

Other specified and unspecified disorders of conjunctiva

2.89

1.51

1.2

2.0

10.58

12.66

umol/l

—

Chronic lymphocytic leukaemia

2.17

1.51

1.8

1.7

12.73

14.98

umol/l

0.53

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

2.17

1.51

1.8

1.7

12.73

14.98

umol/l

0.53

Chronic lymphocytic leukaemia, helper endpoint

2.17

1.51

1.8

1.7

12.73

14.98

umol/l

0.53

Other/unspecified seropositive rheumatoid arthritis

660

1.29

1.49

1.3

1.4

11.95

12.68

umol/l

0.48

624

Gonarthrosis,primary

250

1781

0.86

1.48

1.4

13.16

12.92

umol/l

0.22

235

1688

Diseases of pulp and periapical tissues and dental caries

278

1235

1.15

1.47

1.4

12.70

12.11

umol/l

0.71

262

1178

Combinations of oral blood glucose lowering drugs

715

1.27

1.46

1.3

1.5

15.05

13.14

umol/l

1.52

686

Other specified and unspecified personality disorders

277

1.45

1.44

1.3

1.5

12.60

11.32

umol/l

0.27

263

Other joint disorders

387

1814

1.13

1.43

1.4

11.47

11.72

umol/l

0.33

367

1724

Personal history of malignant neoplasm

157

1.60

1.40

1.3

1.4

13.56

10.79

umol/l

1.14

148

Varicella [chickenpox]

157

1.60

1.40

1.3

1.6

11.86

11.68

umol/l

0.06

147

Colorectal cancer

491

1.32

1.37

1.3

1.4

14.77

14.05

umol/l

0.22

456

Chronic diseases of tonsils and adenoids

337

1887

1.13

1.36

1.3

1.4

10.80

11.99

umol/l

3.38

319

1794

Rotator cuff syndrome

220

1362

1.16

1.34

1.4

12.37

12.76

umol/l

0.38

209

1291

Sequelae of injuries, of poisoning and of other consequences of external causes

708

1.26

1.32

1.5

1.4

11.52

12.41

umol/l

0.80

676

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

655

1.27

1.32

1.3

1.5

12.07

12.55

umol/l

0.29

619

Other (not insulin) diabetes medications

384

2038

1.12

1.32

1.3

1.4

13.80

11.88

umol/l

5.21

349

1957

Gonarthrosis, primary, with knee surgery

132

1262

0.83

1.31

1.4

13.42

13.52

umol/l

0.06

124

1193

Persons encountering health services in circumstances related to reproduction

247

1450

1.15

1.31

1.5

1.4

10.66

11.93

umol/l

3.29

239

1381

Type 1 diabetes, wide definition

665

1.26

1.30

1.4

12.59

11.48

umol/l

0.67

639

Diabetes insipidus

2.80

1.29

1.4

1.8

8.92

11.66

umol/l

—

Other bullous disorders

2.01

1.27

1.0

1.7

14.15

13.14

umol/l

0.11

Congenital malformations of great arteries

2.06

1.27

1.2

1.9

12.76

10.43

umol/l

—

Schizophrenia or delusion

122

1010

1.21

1.27

1.2

1.4

12.19

11.94

umol/l

0.14

974

Spinal stenosis

162

1042

1.18

1.26

1.4

14.47

13.21

umol/l

1.12

154

979

Impotence

130

1.62

1.26

1.6

15.14

13.97

umol/l

0.29

122

Caries of dentine, including avohilmo

324

1471

1.13

1.24

1.4

12.33

11.98

umol/l

0.40

304

1405

Vulvovaginal ulceration/inflammation in other diseases

163

1.54

1.23

1.7

1.4

9.92

9.74

umol/l

0.04

150

Pervasive developmental disorders excl. Autism + Asperger

2.39

1.23

1.8

8.83

9.92

umol/l

—

Adenocarcinoma and ductal carcinoma of pancreas

1.91

1.23

1.5

1.6

11.74

14.36

umol/l

0.59

Endometriosis diagnosis and infertility diagnosis occurring together

304

1.39

1.23

1.5

1.3

10.88

9.77

umol/l

0.71

291

Adenocarcinoma of pancreas

2.05

1.22

1.5

1.7

11.59

14.89

umol/l

—

Transport accidents

172

1267

1.17

1.21

1.3

1.4

12.10

11.55

umol/l

0.55

165

1209

Molar incisor enamel hypoplasia, with caries

2.64

1.21

1.0

1.3

10.96

7.74

umol/l

—

Later onset COPD, excluding more controls

301

1.34

1.19

1.2

1.5

19.71

14.03

umol/l

3.01

282

Dental caries, including avohilmo

299

1357

1.13

1.19

1.4

12.67

12.08

umol/l

0.73

280

1295

Disorders of muscles

264

1.40

1.18

1.4

1.5

11.68

12.47

umol/l

0.36

247

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

219

1.44

1.17

1.2

1.6

9.56

9.89

umol/l

0.21

207

Schizophrenia, schizotypal and delusional disorders

121

1011

1.20

1.17

1.2

1.4

12.21

11.94

umol/l

0.14

975

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

102

1.67

1.16

1.2

1.5

10.27

10.15

umol/l

0.04

Other arthritis (FG)

111

921

1.21

1.15

1.3

1.4

12.65

12.00

umol/l

0.58

102

875

Cervical disc disorders

126

1058

1.19

1.15

1.4

12.27

12.55

umol/l

0.21

118

999

Other acquired deformities of ankle and foot

2.52

1.15

1.0

1.5

11.80

10.63

umol/l

—

Substance use, excluding alcohol

624

1.25

1.15

1.2

1.5

14.06

11.97

umol/l

0.84

601

Carcinoma in situ of skin

166

1.51

1.14

1.8

1.5

14.44

14.10

umol/l

0.09

151

Fracture of lower leg, including ankle

206

1782

1.14

1.2

1.4

11.99

12.26

umol/l

0.24

182

1694

Deviated nasal septum

122

1023

1.19

1.13

1.2

1.4

12.80

13.02

umol/l

0.16

114

971

Acute peritonitis

151

1.53

1.11

1.6

1.4

11.88

13.40

umol/l

0.55

142

Premature separation of placenta [abruptio placentae]

1.97

1.11

1.6

1.4

11.10

9.57

umol/l

—

Otitis externa, unspecified

319

1.35

1.10

1.1

1.5

12.21

11.84

umol/l

0.12

303

Missing teeth due to accident, extraction or parodontitis

199

1640

1.14

1.09

1.4

13.52

12.90

umol/l

0.66

179

1557

Allergic urticaria

235

1.41

1.08

1.3

1.5

11.22

11.20

umol/l

0.01

220

Disorders of speech understanding and production

110

1.61

1.08

1.1

1.5

11.40

10.56

umol/l

0.20

102

Rare circulating lymphoid malignancy, including Hilmo

1.87

1.07

1.2

1.6

14.95

13.22

umol/l

0.29

Pleural plaque

193

0.57

1.07

1.3

1.4

16.80

15.75

umol/l

0.11

177

Amputation of thigh

1.93

1.06

1.1

1.5

17.70

16.14

umol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

106

885

1.20

1.06

1.4

1.5

13.49

12.28

umol/l

0.86

839

Embedded and impacted teeth

114

789

1.19

1.06

1.4

11.11

10.56

umol/l

0.40

109

749

Dental pulpitis, including avohilmo

325

2336

0.90

1.06

1.3

1.4

12.08

11.66

umol/l

0.59

304

2221

Carcinoma in situ of cervix uteri

265

0.64

1.04

1.4

11.86

9.76

umol/l

0.51

247

Dronedarone medication

1.96

1.03

1.2

1.4

10.69

14.63

umol/l

—

Motor disorders, excluding more controls

2.08

1.03

1.3

1.7

7.14

10.61

umol/l

—

Hypoplasia of dental enamel

2.28

1.03

1.0

1.3

10.16

7.86

umol/l

—

Basal cell carcinoma

129

758

1.18

1.02

1.3

1.4

13.90

13.50

umol/l

0.21

123

710

Nontoxic goitre/thyroid nodule

752

1.21

1.02

1.3

1.4

10.66

12.27

umol/l

1.88

712

Malignant neoplasm of skin

155

916

1.16

1.02

1.3

1.4

13.83

13.38

umol/l

0.27

146

860

Mixed disorders of conduct and emotions, excluding more controls

1.90

1.01

1.6

1.8

9.40

9.95

umol/l

—

Other blood glucose lowering drugs, excl. Insulins

368

1.31

1.01

1.3

1.5

13.97

13.24

umol/l

0.23

355

Other diseases of lip and oral mucosa

140

1204

1.16

1.00

1.4

11.11

12.16

umol/l

1.61

130

1147

Postpartum haemorrhage due to anatomy

273

1.36

1.00

1.5

1.3

9.31

9.04

umol/l

0.17

262

Dissociative [conversion] disorders

1.65

1.00

1.4

1.6

9.63

9.91

umol/l

0.04

Injuries to the shoulder and upper arm

323

2356

1.10

1.00

1.4

13.26

12.27

umol/l

1.56

304

2228

Other demyelinating diseases of the central nervous system

115

1.57

0.99

1.1

1.5

10.92

10.39

umol/l

0.15

106

Acute gastritis

172

1.46

0.99

1.4

1.5

15.75

12.89

umol/l

0.74

161

Poisoning by medicine

709

1.21

0.99

1.3

1.4

12.01

11.56

umol/l

0.19

680

Other disorders involving the immune mechanism, not elsewhere classified

1.72

0.99

1.2

1.5

12.92

13.43

umol/l

0.08

Other lesions of median nerve

1.84

0.98

1.1

1.7

13.11

12.17

umol/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

2.19

0.98

1.6

1.7

9.62

10.40

umol/l

—

Graves disease, strict definition

283

1.35

0.98

1.4

1.5

10.37

10.98

umol/l

0.33

266

Cysts of oral region, not elsewhere classified

161

0.56

0.97

1.1

1.5

11.74

12.43

umol/l

—

154

Fibroblastic disorders

566

1.24

0.97

1.3

1.4

11.81

13.29

umol/l

1.07

530

Malignant neoplasm of mesothelium and soft tissue

1.69

0.95

1.5

1.6

12.95

13.59

umol/l

0.09

Hyperprolactinaemia

1.65

0.94

1.1

1.5

10.29

10.42

umol/l

0.03

Open wound of forearm

268

1.35

0.94

1.3

1.5

12.94

12.84

umol/l

0.03

254

Spinal enthesopathy

1.89

0.94

1.3

1.6

12.80

13.26

umol/l

—

Granuloma annulare

2.23

0.93

1.5

1.8

10.58

11.71

umol/l

—

therapeutic use

1.83

0.92

1.3

1.5

15.58

13.46

umol/l

—

Diseases of pulp and periapical tissues, including avohilmo

443

2113

1.09

0.92

1.3

1.4

12.73

11.81

umol/l

1.91

416

2011

COPD

133

938

1.16

0.92

1.4

16.91

13.42

umol/l

3.58

121

877

Oral lichen planus, including avohilmo , including avohilmo

171

0.58

0.91

1.4

1.5

8.98

11.94

umol/l

—

162

Sensorineural hearing loss

210

1598

0.89

0.90

1.4

11.91

13.12

umol/l

2.42

202

1507

Medical abortion

229

1109

1.12

0.90

1.4

10.58

10.86

umol/l

0.33

216

1063

Other and unspecified disorders of psychological development

2.04

0.88

1.0

1.7

8.33

8.32

umol/l

—

Other intervertebral disc disorders

323

1772

1.10

0.88

1.4

12.46

12.09

umol/l

0.43

305

1682

Papulosquamous disorders

135

1173

1.15

0.88

1.4

12.28

12.35

umol/l

0.04

128

1119

Fall on same level involving ice and snow

203

1812

1.12

0.87

1.3

1.4

11.99

12.21

umol/l

0.17

190

1717

Habit and impulse disorders

1.87

0.87

1.4

1.8

14.36

11.25

umol/l

—

Idiopathic pulmonary fibrosis

144

1.46

0.87

1.1

1.5

14.63

15.09

umol/l

0.09

132

Non-follicular lymphoma

212

1.37

0.86

1.4

1.5

15.57

14.35

umol/l

0.39

198

Diabetic neuropathy

280

1.32

0.85

1.2

1.4

13.83

14.60

umol/l

0.19

259

COPD related to multimorbidity

109

788

1.17

0.85

1.3

1.4

18.02

14.08

umol/l

3.26

736

Other acute viral hepatitis

1.95

0.84

1.7

1.5

13.38

10.63

umol/l

—

Other chronic obstructive pulmonary disease

125

892

1.16

0.84

1.3

1.5

17.20

13.43

umol/l

3.74

114

834

Contraceptive management

167

1035

1.13

0.82

1.3

1.4

10.64

11.57

umol/l

1.54

161

995

Malignant neoplasm of small intestine

1.75

0.82

1.3

1.8

19.85

14.24

umol/l

—

Malignant neoplasm of oesophagus

1.75

0.82

1.0

1.7

14.14

14.56

umol/l

—

Vasomotor rhinitis (mode)

201

0.65

0.81

1.1

1.5

10.05

12.29

umol/l

0.96

189

Male infertility

164

0.61

0.80

1.6

12.52

12.66

umol/l

—

159

Diabetic retinopathy, excluding more controls

400

1.19

0.80

1.3

1.4

13.95

13.87

umol/l

0.03

369

Other and unspecified iridocyclitis

114

1.50

0.79

1.1

1.5

11.30

12.18

umol/l

0.40

106

COPD, hospital admissions 1, only main diagnosis

695

1.17

0.78

1.3

1.4

17.93

13.90

umol/l

3.05

646

Allergic rhinitis

121

1043

1.15

0.78

1.3

1.4

9.67

11.14

umol/l

3.10

115

999

Lumbar disc prolapse

242

1684

1.10

0.78

1.3

1.4

12.70

12.08

umol/l

0.65

230

1601

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

538

1.21

0.77

1.2

1.4

11.47

11.38

umol/l

0.03

514

Conductive and sensorineural hearing loss

231

1718

0.91

0.76

1.4

11.81

12.96

umol/l

2.41

222

1625

Substance abuse

222

1889

1.10

0.76

1.3

1.4

13.76

12.35

umol/l

1.66

186

1805

Disease of hard tissues of teeth, NOS

210

988

1.11

0.76

1.3

1.4

11.71

12.15

umol/l

0.52

193

941

Glucagon-like peptide-1 (GLP-1) analogues

101

871

1.16

0.76

1.3

1.4

13.97

11.93

umol/l

2.20

840

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

101

871

1.16

0.76

1.3

1.4

13.97

11.93

umol/l

2.20

840

Erythema nodosum

1.65

0.75

1.3

1.6

12.33

11.67

umol/l

0.10

Impacted cerumen

227

1.32

0.74

1.4

1.5

12.78

13.76

umol/l

0.39

217

Other/unspecified rheumatoid arthritis

289

1.28

0.73

1.2

1.5

12.62

12.71

umol/l

0.02

272

Complications of labour and delivery

188

1163

0.90

0.73

1.4

1.3

9.83

10.90

umol/l

2.15

178

1110

Fracture of neck

133

1.43

0.73

1.6

1.5

12.45

13.91

umol/l

0.55

122

Benign neoplasm: Scapula and long bones of upper limb

2.01

0.73

1.0

1.5

13.94

10.59

umol/l

—

Gonarthrosis

194

1226

0.90

0.72

1.3

1.4

13.09

12.58

umol/l

0.49

182

1171

Deficiency of other B group vitamins

1.80

0.72

1.9

1.8

13.66

13.91

umol/l

—

Pustulosis palmaris et plantaris

106

0.56

0.72

1.2

1.5

13.40

11.89

umol/l

—

100

Disorders of orbit

109

1.47

0.71

1.1

1.5

10.52

11.91

umol/l

0.41

103

Other malignant neoplasms of skin (=non-melanoma skin cancer)

131

792

1.13

0.70

1.3

1.4

13.80

13.50

umol/l

0.15

125

742

Diseases of middle ear and mastoid

228

1699

1.10

0.70

1.3

1.4

11.31

11.50

umol/l

0.19

215

1614

Fall involving bed

1.56

0.70

1.9

1.5

15.97

15.50

umol/l

—

Other appendicitis

240

0.71

0.70

1.4

1.5

11.71

12.49

umol/l

0.15

227

Meralgia paraesthetica

1.56

0.68

1.8

1.4

11.22

11.88

umol/l

0.23

Early onset COPD

574

1.19

0.68

1.4

15.47

13.26

umol/l

1.08

542

Brain meningioma, including Hilmo

117

0.60

0.68

1.1

1.6

8.63

12.46

umol/l

—

109

COPD, hospital admission 2, with asthma infections

643

1.16

0.67

1.3

1.4

17.62

13.97

umol/l

2.31

598

Mental and behavioural disorders due to psychoactive substance use

227

1924

1.09

0.66

1.3

1.4

13.80

12.30

umol/l

1.84

191

1837

Failed induction of labour

179

0.67

0.66

1.2

1.4

8.32

9.71

umol/l

0.95

168

Corns and callosities

162

1.36

0.66

1.5

12.81

13.20

umol/l

0.13

154

Acute bronchiolitis

169

1.34

0.66

1.5

1.4

10.71

10.47

umol/l

0.07

162

Mouth breathing

143

1277

1.12

0.66

1.4

12.53

12.52

umol/l

0.01

134

1216

Other benign neoplasms of connective and other soft tissue

268

1.27

0.65

1.4

1.5

14.21

12.26

umol/l

0.53

251

Lesion of ulnar nerve

376

1.23

0.65

1.4

1.5

12.05

12.38

umol/l

0.15

354

Varicose veins

191

1309

1.10

0.65

1.3

1.4

13.78

12.74

umol/l

1.04

178

1227

Benign lipomatous neoplasm

810

1.15

0.64

1.4

11.95

12.67

umol/l

0.53

769

Vasomotor and allergic rhinitis

142

1248

1.12

0.64

1.3

1.4

10.27

11.49

umol/l

2.05

136

1188

Other inflammation of vagina/vulva

1.48

0.64

1.4

8.30

9.42

umol/l

0.54

Polyarthrosis

434

1.20

0.64

1.2

1.4

11.60

12.78

umol/l

0.76

412

Allergic purpura

1.52

0.62

1.2

1.5

14.12

12.11

umol/l

0.50

Nail disorders

243

1.28

0.62

1.5

11.66

12.00

umol/l

0.14

229

Lichen sclerosus et atrophicus

252

1.27

0.62

1.5

10.13

11.70

umol/l

1.03

240

Other fall from one level to another

682

1.16

0.62

1.2

1.5

11.88

12.34

umol/l

0.31

646

COPD, hospital admissions

125

941

1.12

0.61

1.3

1.4

17.38

13.79

umol/l

3.38

115

880

Contusion of toe(s) with damage to nail

1.67

0.61

1.4

1.5

10.40

11.31

umol/l

—

Basal cell carcinoma, including avohilmo

131

806

1.12

0.60

1.3

1.4

13.76

13.44

umol/l

0.16

125

755

Behavioural disorders, excluding more controls

1.57

0.60

1.3

1.6

9.76

11.14

umol/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

0.00

0.60

0.0

1.6

—

15.27

—

COPD, early/later onset

126

948

1.12

0.60

1.3

1.4

17.38

13.76

umol/l

3.44

115

888

Sub-endpoint used in defining T1D endpoints

101

876

1.13

0.60

1.4

12.65

12.32

umol/l

0.16

834

Open wound of wrist and hand

145

1570

0.90

0.60

1.3

1.4

11.46

12.26

umol/l

0.86

140

1484

Other chronic obstructive pulmonary disease, including avohilmo

157

1173

1.11

0.60

1.4

16.34

13.40

umol/l

3.32

145

1105

Endometriosis of fallopian tube

0.00

0.59

0.0

1.1

—

10.18

—

Sciatica+with lumbago

183

1536

1.10

0.59

1.2

1.4

11.93

12.02

umol/l

0.07

174

1455

Other surgical follow-up care

1.53

0.59

1.5

10.93

11.46

umol/l

0.19

Kela-code for severe mental illness

131

1176

1.11

0.59

1.3

1.4

12.45

11.84

umol/l

0.39

1131

Acute and transient psychotic disorders

366

0.79

0.58

1.1

1.5

11.43

11.84

umol/l

0.18

350

Carrier of infectious disease

1.57

0.58

2.0

1.7

10.62

11.52

umol/l

—

Spontaneous rupture of synovium and tendon

197

0.71

0.58

2.2

1.5

11.42

12.90

umol/l

0.66

184

severe traumatic brain injury, does not include concussion

547

1.17

0.58

1.5

12.84

13.85

umol/l

0.68

511

Other obstetric trauma

140

1.36

0.58

1.4

1.3

10.93

9.66

umol/l

0.61

131

Bronchiectasis

175

1.32

0.58

1.3

1.6

14.37

13.63

umol/l

0.17

163

Burn and corrosion of wrist and hand

106

1.42

0.57

1.3

1.6

13.89

12.06

umol/l

0.35

Macular pucker

328

1.22

0.57

1.3

1.5

13.01

14.03

umol/l

0.40

304

Asthma/COPD (KELA code 203)

376

2422

1.06

0.56

1.3

1.4

12.54

11.79

umol/l

1.10

353

2298

Perioral dermatitis

1.46

0.56

1.5

12.09

10.14

umol/l

—

Coxarthrosis [arthrosis of hip](FG)

171

1097

1.10

0.55

1.4

13.44

12.99

umol/l

0.35

161

1039

Glaucoma-related operations

124

1.37

0.55

1.1

1.5

12.02

14.71

umol/l

0.71

118

Asthma and opportunity respiratory infection

107

1.41

0.55

1.1

1.6

14.01

13.86

umol/l

0.02

Scissor bite

1.47

0.54

1.3

1.4

11.43

9.58

umol/l

0.22

Right bundle-branch block

1.50

0.54

1.0

1.5

13.54

13.12

umol/l

—

Polyhydramnios

126

0.63

0.54

1.3

1.5

9.00

9.48

umol/l

—

117

Other renal tubulo-interstitial diseases

1.48

0.53

1.2

1.4

16.96

10.61

umol/l

—

Coxarthrosis, primary, with hip surgery

106

1108

0.89

0.53

1.5

1.4

13.27

13.66

umol/l

0.24

1040

Alcohol abuse, main dg

479

1.17

0.52

1.1

1.5

14.23

12.50

umol/l

0.79

458

COPD, hospital admissions 3, with asthma pneumonia sepsis

520

1.15

0.52

1.3

1.4

18.80

14.25

umol/l

2.49

482

Fracture of foot, except ankle

761

1.13

0.51

1.4

11.75

11.96

umol/l

0.12

729

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

140

862

1.10

0.51

1.4

13.80

13.45

umol/l

0.20

134

809

Diseases of male genital organs

199

925

1.09

0.51

1.4

14.36

13.36

umol/l

1.15

187

874

Postpartum haemorrhage due to retained placenta

368

0.81

0.49

1.2

1.4

9.79

9.36

umol/l

0.30

355

Periapical abscess

158

1449

1.09

0.49

1.3

1.4

13.04

12.14

umol/l

0.95

147

1382

Palmar fascial fibromatosis [Dupuytren]

334

1.20

0.49

1.3

1.4

12.89

14.13

umol/l

0.44

310

Other neurotic disorders

110

1.37

0.48

1.2

1.5

13.83

13.52

umol/l

0.04

104

Brain meningioma

111

0.63

0.48

1.1

1.6

8.63

12.54

umol/l

—

104

Other acute skin changes due to ultraviolet radiation

1.45

0.48

1.5

11.65

13.29

umol/l

0.37

Excessive earwax

176

1585

1.08

0.48

1.5

1.4

11.80

12.85

umol/l

1.79

158

1506

Carpal tunnel syndrome

182

1734

0.92

0.48

1.3

1.4

12.32

12.14

umol/l

0.14

173

1653

Urethral stricture

128

1.33

0.47

1.3

1.5

16.07

14.29

umol/l

0.34

120

Malignant neoplasm of small intestine, including Hilmo

1.47

0.47

1.5

1.6

17.77

14.17

umol/l

—

Poisoning by drugs, medicaments and biological substances

786

1.12

0.47

1.3

1.4

11.97

11.41

umol/l

0.26

756

Prurigo nodularis

1.46

0.47

1.1

1.6

12.51

14.11

umol/l

—

Alzheimer’s disease (Atypical or mixed)

152

0.72

0.45

1.3

1.4

16.64

16.53

umol/l

0.01

138

Impetigo

138

1.31

0.45

1.4

1.5

11.82

11.34

umol/l

0.12

128

Pustular psoriasis

121

0.66

0.45

1.1

1.5

12.80

11.84

umol/l

—

113

LSIL lesion of the cervix uteri, vagina or vulva

412

1.17

0.45

1.3

1.4

12.51

9.86

umol/l

1.11

395

Unknown and unspecified causes of morbidity

147

1.29

0.45

1.1

1.5

13.86

12.09

umol/l

0.31

140

Hyperplasia of prostate

107

548

1.11

0.45

1.4

15.08

14.59

umol/l

0.27

101

521

Dislocation, sprain and strain of joints and ligaments of knee

232

2001

1.07

0.44

1.3

1.4

11.27

11.75

umol/l

0.80

222

1904

Contact with heat and hot substances

141

0.71

0.44

1.2

1.6

11.33

12.76

umol/l

—

132

Deep endometriosis

253

0.79

0.44

1.2

1.5

9.58

10.85

umol/l

0.64

237

Mandibular retrognathia AND surgery (BSSO)

1.45

0.44

1.1

1.4

10.06

10.14

umol/l

—

Umbilical hernia

780

1.12

0.44

1.2

1.4

13.89

12.66

umol/l

0.86

742

Other diseases of spinal cord

1.45

0.44

1.3

1.6

10.71

12.29

umol/l

—

209

1762

1.07

0.44

1.3

1.4

13.86

12.57

umol/l

1.61

179

1685

Disorders of synovium and tendon

187

1522

1.08

0.44

1.4

10.57

12.07

umol/l

4.35

178

1443

Alcohol use disorder, Swedish definition

194

1656

1.07

0.43

1.3

1.4

13.86

12.61

umol/l

1.43

165

1581

Diffuse large B-cell lymphoma

1.37

0.43

1.2

1.6

19.09

13.96

umol/l

1.46

Diffuse large B-cell lymphoma, including Hilmo

1.37

0.43

1.2

1.6

19.09

13.96

umol/l

1.46

Diffuse large B-cell lymphoma, helper endpoint

1.37

0.43

1.2

1.6

19.09

13.96

umol/l

1.46

Gonarthrosis [arthrosis of knee](FG)

233

1446

0.94

0.43

1.4

12.87

12.51

umol/l

0.36

219

1374

Vascular syndromes of brain in cerebrovascular disorders

1.41

0.43

1.5

1.4

13.76

15.97

umol/l

0.44

Acute nasopharyngitis (common cold)

369

0.83

0.43

1.7

1.5

10.94

12.17

umol/l

1.21

358

Inflammatory disease of cervix uteri

162

0.74

0.42

1.7

1.4

9.98

10.89

umol/l

0.43

153

Dislocation, sprain and strain of joints and ligaments of thorax

1.38

0.42

2.0

1.7

11.73

12.06

umol/l

0.05

Injury of muscle and tendon at shoulder and upper arm level

109

993

1.10

0.42

1.5

1.4

12.19

13.25

umol/l

1.24

104

935

Specific development disorders of scholastic skills

138

1.29

0.42

1.4

10.54

10.65

umol/l

0.04

131

Artificial joint operation, meniscal resection

292

2005

0.94

0.42

1.4

12.41

12.79

umol/l

0.47

278

1902

Optic atrophy

1.52

0.41

1.4

1.8

13.92

12.63

umol/l

—

Other mosquito-borne viral fevers

0.00

0.41

0.0

2.1

—

10.74

—

Infections of genitourinary tract in pregnancy

272

0.81

0.41

1.3

1.4

9.78

10.20

umol/l

0.20

259

Ventricular septal defect, a heart condition

1.35

0.41

1.3

1.5

15.00

9.56

umol/l

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.41

0.0

2.6

—

8.56

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.41

0.0

1.7

—

13.48

—

Fall on and from ladder

177

1.24

0.40

1.3

1.5

12.89

14.22

umol/l

0.37

163

Xanthelasma of eyelid

0.00

0.40

0.0

2.2

—

10.83

—

Other and unspecified injuries of neck

0.00

0.40

0.0

1.8

—

10.15

—

Bilateral sagittal split ramus osteotomy operation

1.37

0.40

1.5

1.4

9.42

10.17

umol/l

0.30

Stomatitis and related lesions

568

1.13

0.40

1.3

1.5

12.13

11.85

umol/l

0.14

540

Chronic nephritic syndrome

1.34

0.39

1.1

1.6

16.62

12.75

umol/l

0.71

Sexual dysfunction

1.43

0.39

1.4

1.7

14.80

12.77

umol/l

—

L02BX Other hormone antagonists and related agents

106

0.66

0.39

1.3

1.5

15.77

15.93

umol/l

—

Biguanides

350

2030

1.05

0.39

1.3

1.4

13.89

11.98

umol/l

4.75

318

1949

Abnormal findings in secretions and smears from cervix uteri vagina vulva

170

1197

1.07

0.38

1.2

1.4

11.09

10.29

umol/l

0.73

162

1142

Ingrowing nail

160

1.25

0.38

1.8

1.5

11.55

12.29

umol/l

0.27

150

Trigeminal neuralgia

151

1.26

0.38

1.3

1.5

12.13

11.95

umol/l

0.05

142

Open bite

170

0.76

0.38

1.2

1.5

7.80

9.84

umol/l

1.72

161

Pregnancy, childbirth and the puerperium

469

0.90

0.37

1.4

1.3

11.28

11.33

umol/l

0.02

447

Disturbances of smell and taste

1.33

0.37

1.3

1.4

11.10

11.84

umol/l

0.19

Coxibs

113

545

1.09

0.37

1.4

11.79

13.40

umol/l

1.90

106

515

Other benign neoplasms of skin

112

1030

1.09

0.37

1.4

12.95

12.50

umol/l

0.24

102

976

Benign neoplasm: Conjunctiva

1.31

0.37

1.1

1.6

11.89

13.13

umol/l

—

Benign neoplasm: Skin of trunk

114

0.70

0.37

1.4

1.5

13.76

12.10

umol/l

—

109

D07AA Corticosteroids, weak (group I)

467

1.13

0.37

1.5

11.85

11.42

umol/l

0.15

444

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

137

1282

0.93

0.36

1.3

11.22

10.33

umol/l

1.09

132

1222

Alcohol dependence

811

1.10

0.36

1.3

1.4

14.73

13.04

umol/l

1.07

778

Ectopic pregnancy

497

1.13

0.36

1.1

1.4

9.88

10.49

umol/l

0.33

477

Supplementary factors related to causes of morbidity and mortality classified elsewhere

103

946

1.09

0.35

1.4

12.65

12.33

umol/l

0.13

901

Lesion of sciatic nerve

0.64

0.35

2.4

1.6

10.38

13.70

umol/l

—

Single spontaneous delivery

119

683

0.92

0.35

1.6

1.3

10.57

11.20

umol/l

0.58

111

647

Viral meningitis

1.32

0.35

1.2

1.6

13.33

10.35

umol/l

0.87

Maternal care for known or suspected disproportion

126

0.71

0.35

1.6

1.3

7.93

9.70

umol/l

—

117

Multiple delivery

276

0.83

0.34

1.4

9.65

10.62

umol/l

0.54

263

Other congenital malformations of skin

118

1.27

0.33

1.0

1.5

7.44

11.05

umol/l

4.29

111

Malignant neoplasm of corpus uteri

144

0.76

0.33

1.0

1.6

9.63

12.04

umol/l

0.57

138

Benign neoplasm: Skin of eyelid, including canthus

382

0.86

0.33

1.2

1.5

12.27

12.90

umol/l

0.29

359

Psoriasis

845

1.09

0.33

1.3

1.4

12.24

12.37

umol/l

0.07

803

Ankylosing spondylitis, ICD10

257

1.17

0.32

1.4

1.5

11.06

12.00

umol/l

0.59

240

Mental and behavioural disorders due to alcohol

180

1634

1.06

0.31

1.3

1.4

13.89

12.49

umol/l

1.66

151

1563

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

131

0.76

0.30

1.1

1.5

12.91

10.78

umol/l

—

124

Glucosamine medication

113

969

0.93

0.30

1.4

12.50

13.66

umol/l

0.97

104

914

Venous complications and haemorrhoids in pregnancy

1.30

0.30

1.1

1.4

12.66

9.84

umol/l

—

Hyperfunction of pituitary gland

129

1.24

0.30

1.1

1.4

9.88

10.80

umol/l

0.33

120

Other enthesopathies

850

1.08

0.30

1.2

1.4

11.59

11.99

umol/l

0.31

805

Chondropathies

467

1.11

0.29

1.4

1.5

13.49

11.93

umol/l

0.63

440

Malignant neoplasm of rectum, including Hilmo

259

1.16

0.29

1.2

1.5

15.07

14.16

umol/l

0.21

238

Degenerative diseases of the nervous system

525

1.09

0.29

1.4

13.72

14.79

umol/l

0.51

489

Wide developmental disorders, excluding more controls

1.31

0.29

1.7

1.6

11.14

10.65

umol/l

0.11

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

206

0.82

0.29

1.2

1.5

15.44

14.12

umol/l

0.24

189

Mental and behavioural disorders due to alcohol, excluding acute intoxication

151

1418

1.06

0.28

1.3

1.4

14.17

12.78

umol/l

1.40

124

1358

Carcinoma in situ of skin of trunk

1.29

0.28

1.1

1.5

13.25

15.72

umol/l

—

Autism spe, excluding more controls

1.27

0.27

2.0

1.6

11.06

10.70

umol/l

—

Polycythaemia vera

1.27

0.27

1.0

1.7

9.76

13.81

umol/l

—

Malignant neoplasm of head and neck

177

1.19

0.27

1.1

1.5

14.72

14.35

umol/l

0.07

162

Sulfonylureas

595

1.08

0.27

1.2

1.5

16.60

14.13

umol/l

2.01

568

Malignant neoplasm of bladder

120

0.75

0.27

1.3

1.5

13.22

15.62

umol/l

—

109

218

1832

1.05

0.27

1.3

1.4

13.73

12.47

umol/l

1.60

188

1752

Congenital malformations of uterus and cervix

1.20

0.26

1.3

1.6

7.17

9.88

umol/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

203

0.84

0.26

1.2

1.5

15.44

14.14

umol/l

0.23

186

Postprocedural musculoskeletal disorders, not elsewhere classified

169

1.18

0.25

1.7

1.5

12.52

13.19

umol/l

0.24

160

Autism

1.23

0.25

1.9

1.5

10.94

9.58

umol/l

—

Pediculosis, acariasis and other infestations

170

0.82

0.25

1.3

1.6

13.22

12.36

umol/l

0.31

163

0.73

0.24

1.2

1.6

11.55

9.46

umol/l

—

Benign neoplasm of other and unspecified sites

1.28

0.24

1.3

1.6

8.94

12.06

umol/l

—

Excessive attrition of teeth

199

1905

1.04

0.23

1.3

1.4

10.86

11.68

umol/l

1.52

187

1816

Alcohol use disorder, ICD-based

138

1309

1.05

0.23

1.3

1.4

14.42

12.69

umol/l

1.78

114

1252

Effects of foreign body entering through natural orifice

775

1.07

0.23

1.5

13.81

12.45

umol/l

1.02

736

Hydatidiform mole

1.25

0.22

1.2

1.6

7.06

10.72

umol/l

—

Primary gonarthrosis, bilateral

134

1208

0.95

0.22

1.4

12.87

13.30

umol/l

0.34

125

1140

Delivery, wide proxy

100

565

0.94

0.22

1.5

1.3

11.21

11.08

umol/l

0.06

533

Ankylosing spondylitis

267

1.12

0.21

1.4

1.5

11.06

12.30

umol/l

0.87

250

Acquired atrophy of ovary and fallopian tube

0.00

0.21

0.0

1.0

—

11.39

—

Nondiabetic hypoglycaemic coma

0.00

0.21

0.0

1.6

—

14.01

—

Abnormal reflex

0.00

0.21

0.0

1.4

—

10.10

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.5

—

12.55

—

Osteochondrosis of ankle, juvenile

0.00

0.21

0.0

1.6

—

8.40

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.5

—

10.27

—

0.00

0.21

0.0

1.7

—

9.99

—

Enthesopathies of lower limb, excluding foot

681

1.07

0.21

1.6

1.5

11.93

11.96

umol/l

0.01

644

Other dermatomyositis

0.00

0.21

0.0

1.6

—

12.92

—

Lower leg

0.00

0.21

0.0

1.5

—

10.83

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.5

—

10.92

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

239

1.13

0.21

1.1

1.5

12.20

11.60

umol/l

0.11

228

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

199

1513

1.04

0.21

1.3

1.4

11.31

11.28

umol/l

0.02

190

1439

Anti-inflammatory and antirheumatic products, non-steroids

122

581

1.06

0.21

1.6

1.4

12.33

13.25

umol/l

0.74

114

551

Carcinoma in situ of breast

0.00

0.21

0.0

2.2

—

12.46

—

Deformity of finger(s)

0.00

0.21

0.0

1.5

—

10.52

—

Cicatricial alopecia [scarring hair loss]

0.00

0.21

0.0

1.6

—

9.92

—

Artrosis, including avohilmo

308

1740

0.97

0.20

1.4

12.38

12.25

umol/l

0.12

291

1663

Caught, crushed, jammed or pinched in or between objects

145

1.17

0.20

1.6

1.5

10.09

12.28

umol/l

1.84

137

Unspecified urinary incontinence

211

1.14

0.20

1.3

1.5

11.76

12.03

umol/l

0.09

199

Cervical root disorders

0.00

0.20

0.0

2.1

—

11.62

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

106

1005

1.06

0.20

1.2

1.4

10.77

11.23

umol/l

0.25

966

Leiomyoma of uterus

202

1101

1.04

0.19

1.4

1.3

10.96

11.12

umol/l

0.12

188

1057

Other specified/unspecified hearing loss

197

0.86

0.19

1.8

1.5

13.85

13.26

umol/l

0.11

186

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

133

0.83

0.19

1.3

1.5

8.70

11.89

umol/l

2.65

125

Recurrent dislocation of patella

146

1.17

0.19

1.2

1.5

13.95

10.01

umol/l

0.95

137

Salpingitis and oophoritis

462

1.08

0.19

1.6

1.4

11.54

11.06

umol/l

0.19

439

Glaucoma

145

1302

0.96

0.19

1.4

12.01

13.56

umol/l

2.46

136

1227

Plantar fascial fibromatosis

251

1.12

0.18

1.3

1.4

10.74

11.80

umol/l

0.61

240

Inguinal hernia

206

1328

1.04

0.18

1.4

12.96

12.93

umol/l

0.02

194

1254

Atopic conjunctivitis

109

1.19

0.18

1.5

1.6

11.90

10.36

umol/l

0.50

101

Arthrosis

241

1367

0.97

0.18

1.3

1.4

12.51

12.32

umol/l

0.16

227

1308

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

960

0.95

0.18

1.4

12.13

11.68

umol/l

0.29

917

Coxarthrosis

153

969

1.04

0.18

1.4

13.51

13.12

umol/l

0.27

143

924

Acute appendicitis

257

2331

1.03

0.17

1.3

1.4

12.16

11.81

umol/l

0.41

248

2210

0.72

0.17

1.2

1.6

12.46

8.73

umol/l

—

Gestational diabetes (for exclusion)

122

886

0.96

0.16

1.4

1.3

9.02

9.78

umol/l

1.51

114

857

Contusion of toe(s) without damage to nail

1.14

0.16

1.3

1.5

8.85

11.23

umol/l

—

Diabetic retinopathy

103

612

1.05

0.16

1.3

1.4

13.57

14.40

umol/l

0.55

563

Benign neoplasm of thyroid gland

1.11

0.16

1.0

1.5

10.29

11.71

umol/l

—

Foreign body on external eye

463

0.93

0.16

1.5

13.60

13.01

umol/l

0.23

440

Crossbite

208

1.11

0.16

1.2

1.4

10.08

10.68

umol/l

0.20

200

Appendectomy

239

2220

1.03

0.16

1.3

1.4

11.33

11.68

umol/l

0.42

231

2112

Primary open-angle glaucoma

677

1.06

0.16

1.4

12.78

14.19

umol/l

0.99

636

Autism spe

1.10

0.15

2.0

1.5

11.06

9.51

umol/l

—

Type of accident

877

1.05

0.15

1.4

12.42

12.38

umol/l

0.01

835

Diseases of appendix

275

2414

1.03

0.15

1.3

1.4

12.16

11.84

umol/l

0.36

266

2289

Exposure to other and unspecified inanimate mechanical forces

216

1.11

0.15

1.4

1.5

14.25

12.14

umol/l

0.52

205

Other and unspecified tonsillitis

136

1100

1.04

0.15

1.4

11.16

11.19

umol/l

0.02

128

1057

Suppurative and unspecified otitis media

137

1169

1.04

0.15

1.3

1.4

10.64

11.20

umol/l

0.63

130

1111

Pathological resorption of teeth

0.80

0.14

1.1

1.6

10.89

12.64

umol/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.79

0.14

1.4

1.6

9.74

11.84

umol/l

—

Open wound of hip and thigh

0.79

0.14

1.6

1.7

11.00

11.85

umol/l

—

Hypercalcemia

1.18

0.14

1.7

1.6

14.70

14.45

umol/l

0.02

Endovascular or surgical operations to intracerebral aneurysms

131

1.15

0.14

1.1

1.6

10.30

13.22

umol/l

1.82

125

Malignant neoplasm of prostate

417

0.95

0.14

1.3

1.5

14.55

15.29

umol/l

0.37

387

Acute appendicitis, no complications

204

1974

1.03

0.14

1.3

1.4

12.05

11.67

umol/l

0.38

196

1874

Poor fetal growth

373

1.07

0.13

1.3

1.4

9.85

9.34

umol/l

0.27

355

Melanocytic naevi of other and unspecified parts of face

159

0.88

0.13

1.1

1.5

11.56

11.29

umol/l

0.04

149

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.17

0.13

1.7

1.6

12.37

13.67

umol/l

0.16

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

117

0.85

0.13

1.4

1.5

11.94

11.83

umol/l

—

111

Delivery

126

689

0.96

0.13

1.6

1.3

10.51

11.19

umol/l

0.62

118

653

Malignant neoplasm of prostate, including Hilmo

431

0.95

0.13

1.3

1.5

14.61

15.18

umol/l

0.27

400

1.17

0.12

1.1

1.6

14.28

13.80

umol/l

0.06

Alzheimer disease, including avohilmo

511

1.05

0.12

1.4

14.51

14.96

umol/l

0.16

477

Placenta praevia

123

1.14

0.12

1.5

1.4

10.59

9.28

umol/l

0.53

114

Schizoaffective disorder

241

0.91

0.12

1.1

1.5

15.33

11.59

umol/l

0.47

231

Artificial joint re-operation

158

0.89

0.12

1.6

1.5

16.65

13.94

umol/l

0.49

148

Other juvenile arthritis

116

0.86

0.12

1.4

1.5

10.60

9.93

umol/l

—

109

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

114

1.14

0.11

1.6

1.5

18.73

12.64

umol/l

0.76

108

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.16

0.11

1.2

1.6

14.98

14.25

umol/l

—

Complications predominantly related to the puerperium

811

0.96

0.10

1.4

8.95

10.27

umol/l

1.28

780

Pregnancy with abortive outcome

210

1121

0.98

0.10

1.2

1.4

10.60

10.89

umol/l

0.27

199

1075

Maternal care related to the fetus and amniotic cavity and possible delivery problems

158

903

1.03

0.10

1.3

9.60

10.26

umol/l

1.04

153

862

Viral conjunctivitis

1.15

0.10

1.5

9.24

11.09

umol/l

1.12

Appendicitis, broad definition

271

2406

1.02

0.10

1.3

1.4

12.19

11.84

umol/l

0.40

262

2281

Other disorders of male genital organs

106

1.13

0.09

1.8

1.6

13.63

13.48

umol/l

0.03

100

Propionic acid derivatives

119

581

1.03

0.09

1.6

1.4

12.09

13.25

umol/l

0.95

110

551

Other abnormal findings of blood chemistry

116

1.12

0.09

1.2

1.6

12.70

12.06

umol/l

0.13

110

Sacroiliitis, not elsewhere classified

136

1.10

0.08

1.3

1.5

10.86

10.61

umol/l

0.06

127

Renal cell carcinoma of kidney

1.03

0.08

1.8

1.7

18.17

14.52

umol/l

—

Impingement syndrome of shoulder

632

0.97

0.07

1.4

12.93

12.79

umol/l

0.06

599

Pleural plaque without asbestos

0.83

0.07

1.0

1.6

19.30

16.27

umol/l

—

malignant neoplasm of male genital organs

453

0.97

0.07

1.3

1.5

14.93

15.01

umol/l

0.03

420

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.12

0.07

1.3

16.64

15.69

umol/l

0.07

Contact with other hot fluids

1.03

0.07

1.3

1.6

11.97

12.32

umol/l

—

Injury of nerves at wrist and hand level

112

0.89

0.07

1.3

1.6

12.80

12.83

umol/l

—

106

Effects of other external causes

0.86

0.07

1.0

1.6

8.97

11.88

umol/l

—

Other maternal disorders predominantly related to pregnancy

195

1202

1.02

0.07

1.4

1.3

10.59

10.53

umol/l

0.04

184

1152

Follicular lymphoma, hilmo

1.03

0.07

1.3

1.5

14.38

14.83

umol/l

—

Benign neoplasm: Long bones of lower limb

0.84

0.06

1.0

1.6

9.65

11.94

umol/l

—

Coxarthrosis, primary

158

1361

0.98

0.06

1.4

13.35

13.43

umol/l

0.04

148

1280

Gluteal tendinitis

101

0.89

0.06

2.2

1.6

10.27

11.59

umol/l

—

Infections of breast associated with childbirth

102

0.88

0.06

1.8

1.4

8.39

9.44

umol/l

—

Other hammer toe(s) (acquired)

354

1.04

0.06

1.2

1.4

12.48

13.00

umol/l

0.23

336

Struck by thrown, projected or falling objec

148

1.08

0.06

1.1

1.6

11.38

12.75

umol/l

0.57

140

Meniscus derangement

189

1255

1.01

0.05

1.5

1.4

11.74

12.54

umol/l

1.23

182

1197

Foreign body or object entering through skin

192

0.94

0.05

1.1

1.5

11.94

12.08

umol/l

0.03

182

Malignant neoplasm of rectum

202

0.94

0.05

1.2

1.5

15.34

14.13

umol/l

0.24

185

Mental and behavioural disorders due to sedatives or hypnotics

208

1.06

0.05

1.0

1.6

12.99

11.90

umol/l

0.21

199

Schizophrenia

515

1.03

0.05

1.1

1.5

13.40

12.22

umol/l

0.36

492

Generalized epilepsy

120

0.92

0.05

1.0

1.6

9.62

11.50

umol/l

0.45

111

Suicide or other Intentional self-harm

793

1.02

0.04

1.2

1.4

11.72

11.69

umol/l

0.01

760

Ganglion

605

0.98

0.04

1.4

10.10

11.81

umol/l

1.82

574

Juvenile osteochondrosis

1.10

0.04

1.2

1.5

11.75

10.90

umol/l

—

Spontaneous abortion

146

997

0.99

0.04

1.3

1.4

10.31

10.55

umol/l

0.19

139

956

Internal derangement of knee

119

1200

0.99

0.03

1.3

1.4

11.20

12.09

umol/l

1.16

113

1142

Necrosis of pulp, including avohilmo

206

2037

1.01

0.03

1.3

1.4

12.28

11.66

umol/l

0.77

196

1937

Tooth agenesis EXCLUDE clefts and syndromes

118

0.93

0.03

1.5

8.69

10.22

umol/l

1.09

113

Contact with sharp glass

118

0.93

0.02

1.3

1.6

9.86

11.40

umol/l

0.52

111

Wide developmental disorders

102

1.08

0.02

1.7

1.5

11.14

9.83

umol/l

0.39

LSIL lesion of the cervix uteri

319

0.97

0.02

1.2

1.4

10.23

9.86

umol/l

0.10

305

Tonsillectomy and adenotomy

226

1583

0.99

0.02

1.3

1.4

10.04

11.06

umol/l

2.67

217

1506

Primary open-angle glaucoma, strict

569

1.02

0.02

1.4

11.46

14.51

umol/l

3.52

534

Suggestive for eosinophilic asthma

238

0.97

0.02

1.0

1.6

13.93

13.14

umol/l

0.19

225

Redundant prepuce, phimosis and paraphimosis

674

1.01

0.01

1.2

1.4

14.00

12.98

umol/l

0.58

634

Acute suppurative otitis media

913

0.99

0.01

1.4

10.54

10.97

umol/l

0.44

865

Other disorders of ear

320

2102

1.00

0.01

1.4

11.88

12.45

umol/l

0.85

301

1994

Scabies

126

0.95

0.00

1.3

1.7

12.51

12.40

umol/l

0.03

120

Labour and delivery complicated by umbilical cord complications

134

1.05

0.00

1.1

1.4

13.13

10.44

umol/l

0.81

126

Disorders of continuity of bone

286

0.98

0.00

1.3

1.5

12.38

12.22

umol/l

0.05

271

Later onset COPD

467

0.99

0.00

1.2

1.4

19.70

15.10

umol/l

2.46

427

Follicular cysts of skin and subcutaneous tissue

516

0.99

0.00

1.2

1.5

13.31

12.62

umol/l

0.28

491

Injuries to the wrist and hand

377

2606

1.00

0.00

1.4

12.14

11.97

umol/l

0.19

360

2473

Oter anti-inflammatory and antirheumatic agents, non-steroids

375

1.00

0.00

1.5

1.4

12.43

14.15

umol/l

1.28

358

Amblyopia ex anopsia

105

1.05

0.00

1.1

1.5

11.20

11.15

umol/l

0.01

Certain conditions originating in the perinatal period

262

0.98

0.00

1.3

1.4

11.59

10.18

umol/l

0.36

247

Other and unspecified injuries of lower leg

205

1.02

0.00

1.6

1.4

13.06

11.71

umol/l

0.50

197

LeFortI or BSSO operation

119

1.01

0.00

1.5

1.6

9.42

10.29

umol/l

0.36

112

Contact with other sharp object(s)

215

0.98

0.00

1.1

1.5

10.84

11.82

umol/l

0.45

203

Juvenile arthritis (FINNGEN)

129

1.01

0.00

1.3

1.4

10.25

9.70

umol/l

0.14

122

Acetic acid derivatives and related substances

101

526

1.00

0.00

1.3

1.4

12.36

13.36

umol/l

0.63

498

Maternal care for known or suspected abnormality of pelvic organs

612

1.00

0.00

1.3

10.01

9.97

umol/l

0.02

583

Acute alcohol intoxication, ICD10

622

1.00

0.00

1.1

1.5

13.32

12.58

umol/l

0.36

596

Acute alcohol intoxication

772

1.00

0.00

1.1

1.5

14.41

12.82

umol/l

0.91

738

Abrasion of teeth

103

1029

1.00

0.00

1.4

11.86

11.87

umol/l

0.00

981

Pyogenic arthritis

166

1.02

0.00

1.2

1.5

13.12

13.37

umol/l

0.07

157

Endometriosis of rectovaginal septum and vagina

177

1.02

0.00

1.2

1.4

9.70

11.10

umol/l

0.64

169

Crushing injury of lower leg

0.00

0.0

1.4

—

8.80

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.5

—

11.67

—

Cutaneous lupus erythematosus

1.02

0.00

1.4

1.7

12.92

11.49

umol/l

—

Vitreous prolapse

0.00

0.0

1.2

—

11.60

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.2

—

14.40

—

Burn and corrosion of other internal organs

0.00

0.0

1.4

—

10.20

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.0

1.4

—

18.60

—

Myiasis

0.00

0.0

1.8

—

17.22

—

Other acantholytic disorders

0.00

0.0

1.7

—

15.87

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

1.5

—

9.00

—

Occupant of streetcar injured in transport accident

0.00

0.0

1.6

—

10.60

—

Enteropathogenic Escherichia coli infection

0.00

0.0

1.2

—

11.80

—

Colour vision deficiencies

0.00

0.0

1.8

—

9.25

—

Disorders of puberty, other/unspecified

0.00

0.0

1.6

—

9.11

—

Upper arm

0.00

0.0

2.0

—

16.42

—

Moderate mental retardation

0.00

0.0

1.4

—

10.60

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.01

0.00

1.0

1.6

9.61

11.51

umol/l

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.8

—

10.33

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.2

—

12.33

—

Retarded development following protein-energy malnutrition

0.00

-0.00

0.0

1.6

—

10.00

—

Melanoma in situ of scalp and neck

0.00

-0.00

0.0

2.1

—

15.73

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

-0.00

0.0

1.9

—

16.30

—

Labyrinthine fistula

0.00

-0.00

0.0

1.8

—

12.35

—

Disorder of mineral metabolism, other/unspecified

0.00

-0.00

0.0

2.2

—

15.42

—

Cyst of spleen

0.00

-0.00

0.0

1.4

—

10.80

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

1.2

—

17.80

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

-0.00

0.0

1.4

—

9.20

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

-0.00

0.0

1.7

—

13.57

—

Benign neoplasm: Floor of mouth

0.00

-0.00

0.0

1.4

—

11.00

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.6

—

14.40

—

Photocontact dermatitis [berloque dermatitis]

0.00

-0.00

0.0

2.0

—

17.62

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.2

—

12.00

—

Malignant neoplasm of penis

0.00

-0.00

0.0

1.9

—

17.13

—

Psoas tendinitis

0.00

-0.00

0.0

1.6

—

9.87

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

1.7

—

9.00

—

Changes in corneal membranes

0.00

-0.00

0.0

1.5

—

10.67

—

Pityriasis lichenoides chronica

0.00

-0.00

0.0

1.6

—

11.44

—

Factitial dermatitis

0.00

-0.00

0.0

1.2

—

15.50

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

-0.00

0.0

1.6

—

16.64

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

2.0

—

14.22

—

Airway disease due to specific organic dust

0.00

-0.00

0.0

1.5

—

9.67

—

Congenital myopathies

0.00

-0.00

0.0

1.2

—

9.17

—

Other and unspecified mononeuropathies of lower limb

0.89

-0.00

1.4

1.6

19.40

12.00

umol/l

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.2

—

12.20

—

Other congenital malformations of skull and face bones

0.00

-0.00

0.0

1.5

—

7.83

—

Frontotemporal dementia

0.00

-0.00

0.0

1.7

—

14.76

—

Benign neoplasm: Skin, unspecified

0.92

-0.00

1.0

1.5

15.82

12.62

umol/l

—

Contact urticaria

0.00

-0.00

0.0

1.4

—

8.00

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.1

—

12.57

—

Primary angle-closure glaucoma

0.94

-0.00

1.6

1.4

12.96

15.27

umol/l

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

-0.00

0.0

2.2

—

13.17

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

2.0

—

8.94

—

Myiasis

0.00

-0.00

0.0

1.8

—

17.22

—

Polyglandular dysfunction

0.00

-0.00

0.0

1.2

—

18.40

—

Benign neoplasm: Heart

0.00

-0.00

0.0

1.3

—

11.29

—

Absence of one kidney

0.00

-0.00

0.0

2.0

—

11.40

—

Use of peginterferon beta-1a

0.00

-0.00

0.0

1.6

—

8.20

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.6

—

9.71

—

Abscess of Bartholin gland

0.95

-0.00

1.7

1.4

9.79

9.61

umol/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.98

-0.00

1.1

1.3

9.44

9.12

umol/l

—

Aortic stenosis

0.00

-0.00

0.0

2.0

—

13.35

—

Other and unspecified hypertrophic disorders of skin

0.00

-0.00

0.0

1.2

—

12.00

—

Imperforate hymen

0.00

-0.00

0.0

2.0

—

10.60

—

Lichenoid drug reaction

0.00

-0.00

0.0

1.2

—

13.00

—

Transient acantholytic dermatosis [Grover]

0.00

-0.00

0.0

1.8

—

16.18

—

Necrobiosis lipoidica, not elsewhere classified

0.00

-0.00

0.0

1.3

—

12.00

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

1.8

—

9.17

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.6

—

9.20

—

Klinefelter syndrome, karyotype 47 XXY

0.00

-0.00

0.0

1.6

—

9.20

—

Erythema annulare centrifugum

0.00

-0.00

0.0

1.8

—

16.18

—

Toxic erythema

0.00

-0.00

0.0

1.3

—

13.17

—

Hair colour and hair shaft abnormalities

0.00

-0.00

0.0

1.6

—

13.71

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.4

—

13.14

—

Maxillary prognathism

0.00

-0.00

0.0

1.7

—

9.22

—

Posteruptive colour changes of dental hard tissues

0.00

-0.00

0.0

2.8

—

8.76

—

Renal agenesis and other reduction defects of kidney

0.00

-0.00

0.0

2.1

—

10.43

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.6

—

15.01

—

Delayed milestone in childhood

0.94

-0.00

1.2

1.8

12.80

8.82

umol/l

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.8

—

16.68

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.5

—

11.67

—

Other specified/unspecified disorders of tympanic membrane

0.00

-0.00

0.0

1.9

—

10.50

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

1.4

—

8.86

—

Chronic myringitis

0.00

-0.00

0.0

1.1

—

12.71

—

Assault by hanging, strangulation and suffocation

0.00

-0.00

0.0

1.8

—

9.67

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

1.7

—

14.68

—

Other specified/unspecified disorders of ear

0.00

-0.00

0.0

1.9

—

11.01

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.5

—

10.00

—

Exposure to ignition of highly flammable material

0.00

-0.00

0.0

1.8

—

9.83

—

Operations 1 for CAVS

0.00

-0.00

0.0

1.8

—

15.02

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

-0.00

0.0

1.3

—

10.83

—

Meningitis, viral

0.00

-0.00

0.0

1.9

—

14.87

—

Sleep terrors [night terrors]

0.00

-0.00

0.0

2.2

—

11.33

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.2

—

10.00

—

Personal history of allergy to analgesic agent

0.00

-0.00

0.0

1.5

—

10.75

—

Vaginal lichen planus

0.00

-0.00

0.0

1.4

—

10.64

—

Pregnant state, incidental

0.00

-0.00

0.0

2.4

—

10.30

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.3

—

10.63

—

Epileptic seizures related to drugs

0.00

-0.00

0.0

1.3

—

11.00

—

Choroidal detachment

0.00

-0.00

0.0

1.8

—

11.35

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

-0.00

0.0

1.5

—

8.67

—

Sequelae of inflammatory diseases of the central nervous system

0.00

-0.00

0.0

1.5

—

13.00

—

Adrenogenital disorders

0.00

-0.00

0.0

2.0

—

20.83

—

Secondary sideroblastic anaemia

0.00

-0.00

0.0

2.2

—

17.02

—

Immunodeficiency associated with other major defects

0.00

-0.00

0.0

1.5

—

10.17

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Homocysteine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS